nephrosclerosis: Hardening of the walls of the small arteries and arterioles (small arteries that convey blood from arteries to the even smaller capillaries) of the kidney. This condition is caused by hypertension (high blood pressure)
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1413 |
4. Check minimum number of eventsNone |
1413 |
5. Include endpointsNone |
1413 |
6. Filter based on genotype QC (FinnGen only) |
1413 |
Control definitions (FinnGen only)
- Control exclude
- I9_HYPERTENSION
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- I10-I15
- Name in latin
- Morbus hypertensivus renalis
Similar endpoints
↥List of similar endpoints to
Hypertensive Renal Disease
based on the number of shared cases.
Similar with more cases:
- Hypertensive heart and/or renal disease
- Hypertension
- Hypertensive diseases (excluding secondary)
- Hypertensive diseases
- Cardiovascular diseases (excluding rheumatic etc)
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 14004 | 5705 | 8046 |
| Only index persons | 9620 | 3999 | 5621 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.20 | 0.16 | 0.22 |
| Only index persons | 0.19 | 0.15 | 0.21 |
| Median age at first event (years) | |||
| Whole population | 70.24 | 73.64 | 68.06 |
| Only index persons | 72.51 | 76.08 | 69.97 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1413 | 470 | 943 |
| Unadjusted period prevalence (%) | 0.33 | 0.16 | 0.42 |
| Median age at first event (years) | 68.26 | 66.22 | 69.27 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1273
- Matched controls
- 12729
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
205
Kela drug reimbursment
Chronic hypertension
+∞
323.0
926
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
322.5
323.0
429
20
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
59.4
323.0
649
219
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
210.9
323.0
363
24
I12.0
ICD-10 Finland
Hypertensive renal disease with renal failure
12297.9
323.0
899
*
A11CC03
ATC
alfacalcidol; systemic
122.7
323.0
349
39
I10
ICD-10 Finland
Essential (primary) hypertension
18.5
323.0
1036
2434
C08CA01
ATC
amlodipine; oral
11.2
321.1
795
1641
N18.8
ICD-10 Finland
Other chronic renal failure
75.9
307.4
345
62
C03CA01
ATC
furosemide; systemic
8.7
269.5
883
2634
A12AA04
ATC
calcium carbonate; oral
187.2
262.4
267
18
40399
ICD-8 Finland
Hypertensive renal disease
+∞
256.1
237
*
TK800
NOMESCO Finland
Hemodialysis
97.3
230.6
251
32
C02AC05
ATC
moxonidine; oral
91.6
228.9
251
34
M04AA01
ATC
allopurinol; systemic
9.9
223.9
519
823
Z49.1
ICD-10 Finland
Extracorporeal dialysis
220.3
201.7
204
11
N18.0
ICD-10 Finland
End-stage renal disease
127.6
192.7
204
19
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
348.4
181.1
179
6
C08CA02
ATC
felodipine; oral
16.7
176.7
296
226
B03XA02
ATC
darbepoetin alfa; parenteral
43.1
175.5
219
61
I12.9
ICD-10 Finland
Hypertensive renal disease without renal failure
+∞
171.8
161
*
Z49.0
ICD-10 Finland
Preparatory care for dialysis
313.6
164.8
164
6
C09AA02
ATC
enalapril; systemic
7.4
163.9
456
893
C08CA13
ATC
lercanidipine; oral
11.2
161.9
331
387
Z94.0
ICD-10 Finland
Kidney transplant status
833.8
153.6
148
*
137
Kela drug reimbursment
Uraemia requiring dialysis
558.4
153.1
149
*
N19
ICD-10 Finland
Unspecified kidney failure
21.2
148.9
226
128
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
+∞
131.6
124
*
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
1382.6
130.6
125
*
V03AE01
ATC
polystyrene sulfonate; oral
80.8
128.6
144
20
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
1260.9
119.8
115
*
B05DA
ATC
Isotonic solutions
429.3
119.7
118
*
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
95.6
117.6
129
15
I11.9
ICD-10 Finland
Hypertensive heart disease without (congestive) heart failure
149.6
116.4
122
9
C07AG02
ATC
carvedilol; oral
13.5
114.4
208
182
127
Kela drug reimbursment
Transplant complication
59.7
114.3
134
25
4019X
ICD-9 Finland
Essential hypertension, Unspecified
+∞
114.3
108
*
Z49.2
ICD-10 Finland
Other dialysis
598.5
112.7
110
*
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
27.3
107.6
150
62
A12BA01
ATC
potassium chloride; oral
18.1
105.2
168
106
B05DB
ATC
Hypertonic solutions
545.0
103.1
101
*
C07AB07
ATC
bisoprolol; oral
3.6
100.4
793
4015
M10.9
ICD-10 Finland
Gout, unspecified
8.7
97.4
224
303
L04AA06
ATC
mycophenolic acid; systemic
44.1
96.8
120
30
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
13.1
96.7
177
155
C09BA02
ATC
enalapril and diuretics; systemic
13.6
94.8
170
142
40199
ICD-8 Finland
Essential benign hypertension
+∞
90.7
86
*
C09CA01
ATC
losartan; oral
4.3
87.0
391
1197
N17.9
ICD-10 Finland
Acute renal failure, unspecified
11.3
86.6
170
171
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
+∞
86.4
82
*
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
451.8
86.1
85
*
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
4.1
86.1
406
1298
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
8.2
85.8
204
288
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
884.9
85.6
83
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.0
84.5
309
765
I50.9
ICD-10 Finland
Heart failure, unspecified
4.3
84.2
372
1115
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
+∞
82.2
78
*
C02EA02
ATC
NA
20.7
81.9
124
66
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
7.5
80.9
204
314
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
8.1
80.0
192
274
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
9.9
77.9
164
187
C07AB02
ATC
metoprolol; systemic
3.6
77.3
432
1573
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.1
77.3
681
3465
C03AA03
ATC
hydrochlorothiazide; oral
7.7
76.7
189
280
A10BH05
ATC
linagliptin; oral
11.1
76.6
151
152
103
Kela drug reimbursment
Diabetes, insulin-treated
3.6
76.4
436
1611
TK820
NOMESCO Finland
Peritoneal dialysis
+∞
75.8
72
*
196
Kela drug reimbursment
Paricalcitol and cinacalcet
389.1
74.5
74
*
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
261.4
73.1
74
*
215
Kela drug reimbursment
Diabetes, non-insulin-treated
3.9
73.1
363
1188
C10AA05
ATC
atorvastatin; oral
3.0
71.5
621
3072
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
92.2
70.8
78
9
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
4.8
70.4
263
654
V03AE02
ATC
sevelamer; oral
715.5
69.7
68
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
3.6
68.8
377
1329
H05BX01
ATC
cinacalcet; oral
187.7
68.8
71
*
C08CA05
ATC
nifedipine; systemic
7.0
68.7
182
298
C09CA03
ATC
valsartan; oral
7.5
68.4
172
261
I15.0
ICD-10 Finland
Renovascular hypertension
+∞
68.3
65
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
38.3
67.6
86
24
TK810
NOMESCO Finland
Hemofiltration
182.1
66.7
69
*
C10AA01
ATC
simvastatin; oral
2.8
66.1
712
3969
C02CA01
ATC
prazosin; oral
21.0
66.0
99
51
C09CA06
ATC
candesartan; oral
4.1
65.7
298
890
I11.0
ICD-10 Finland
Hypertensive heart disease with (congestive) heart failure
121.4
64.5
69
6
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
339.9
64.0
64
*
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
+∞
63.0
60
*
KA1AE
NOMESCO Finland
Kidney ultrasound examination
14.3
62.7
109
83
B03XA01
ATC
erythropoietin; parenteral
27.8
62.5
86
33
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.5
61.9
339
1180
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
4.2
61.5
262
734
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
5.2
58.6
197
431
U14
ICPC
Kidney symptom/complaint
20.7
57.8
87
45
4039A
ICD-9 Finland
Hypertensive renal disease, Unspecified
+∞
57.7
55
*
B01AC04
ATC
clopidogrel; oral
3.5
56.1
311
1082
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
27.2
55.7
77
30
I25.1
ICD-10 Finland
Atherosclerotic heart disease
2.9
55.7
453
2060
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
5.6
55.6
175
354
TPX10
NOMESCO Finland
Implantation of vascular injection port
11.3
54.9
106
101
SPAT1262
SPAT
Handing over of treatment supplies
3.5
54.8
301
1038
A10AE04
ATC
insulin glargine; parenteral
5.7
54.5
168
331
B01AA03
ATC
warfarin; systemic
2.9
54.0
432
1935
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
8.6
53.2
120
152
321
Kela drug reimbursment
Paricalcitol and cinacalcet
117.0
52.2
56
5
V03AE03
ATC
lanthanum carbonate; oral
528.3
51.8
51
*
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
+∞
51.4
49
*
T90
ICPC
Diabetes non-insulin dependent
3.2
51.3
324
1233
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
180.4
50.3
52
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.2
50.2
310
1158
I50.0
ICD-10 Finland
Congestive heart failure
4.2
49.9
208
563
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.4
49.7
284
1000
C08DB01
ATC
diltiazem; oral
6.7
49.5
133
219
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.8
49.4
238
732
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
+∞
49.3
47
*
C09DA01
ATC
losartan and diuretics; oral
6.0
49.2
144
265
L04AD01
ATC
ciclosporin; systemic
19.4
48.9
75
41
E66.00
ICD-10 Finland
Metabolic syndrome
13.3
48.8
87
70
PG5DE
NOMESCO Finland
Ultrasound examination of injection gate to artery or vein with Doppler method
495.8
48.7
48
*
M10.3
ICD-10 Finland
Gout due to impairment of renal function
132.6
48.1
51
*
TPH04
NOMESCO Finland
Cathetrisation of vein
3.0
48.1
339
1383
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
2.8
47.9
372
1615
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
3.2
47.9
287
1046
ZX120
NOMESCO Finland
Intravenous
4.2
47.9
198
531
C03DA01
ATC
spironolactone; oral
3.9
46.9
213
621
I48
ICD-10 Finland
Atrial fibrillation and flutter
2.6
46.6
447
2193
I15.9
ICD-10 Finland
Secondary hypertension, unspecified
+∞
46.1
44
*
C01DA14
ATC
isosorbide mononitrate; oral
2.8
44.5
345
1484
N18
ICD-10 Finland
Chronic kidney disease
24.5
44.4
63
27
PBL09
NOMESCO Finland
Construction of arteriovenous fistula from brachial artery
+∞
44.0
42
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.4
42.9
504
2726
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.5
42.7
433
2165
R80
ICD-10 Finland
Isolated proteinuria
39.4
42.2
53
14
3AC01
NOMESCO Finland
NA
22.4
41.3
60
28
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
148.1
41.0
43
*
ZXD05
NOMESCO Finland
Urgent procedure
2.4
40.2
443
2301
C09DA06
ATC
candesartan and diuretics; oral
7.7
39.9
96
134
D64.9
ICD-10 Finland
Anaemia, unspecified
3.3
39.9
221
751
I12
ICD-10 Finland
Hypertensive renal disease
+∞
39.8
38
*
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
206.2
39.0
40
*
N03.9
ICD-10 Finland
Chronic nephritic syndrome, unspecified
88.9
39.0
43
5
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
5.4
38.6
122
245
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
2.4
38.5
414
2114
A10BA02
ATC
metformin; oral
2.5
37.6
350
1649
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
3.1
37.6
231
842
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.7
37.5
176
523
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.1
37.3
156
418
L04AA01
ATC
[U] ciclosporin; systemic
19.2
37.3
57
31
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
5.5
37.2
116
229
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
3.0
37.2
241
910
C03BA11
ATC
indapamide; oral
17.1
37.1
59
36
A46
ICD-10 Finland
Erysipelas
3.0
37.0
237
888
R4190
NOMESCO Finland
Nutritional therapy
9.2
37.0
79
91
A10BH01
ATC
sitagliptin; oral
4.3
36.6
147
379
Z3231
NOMESCO Finland
Registered nurse
2.4
36.5
403
2075
C02DE10
ATC
NA
70.4
36.1
41
6
R06.0
ICD-10 Finland
Dyspnoea
2.5
36.1
354
1712
WX722
NOMESCO Finland
PEEP
6.0
35.7
102
181
WW200
NOMESCO Finland
Immunization
9.4
35.7
75
84
C10AA04
ATC
fluvastatin; oral
3.4
35.1
184
596
K65.0
ICD-10 Finland
Acute peritonitis
11.3
34.7
66
61
RD210
NOMESCO Finland
NA
14.3
34.6
59
43
AA1AD
NOMESCO Finland
CT of head and brain
2.4
34.6
350
1716
N02BE01
ATC
paracetamol; systemic, rectal
2.3
34.5
1023
8105
XF602
NOMESCO Finland
Bloodpressure monitoring
40.4
34.5
43
11
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
4.5
34.4
130
316
TPH07
NOMESCO Finland
Cathetrisation of artery
3.6
34.3
171
532
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.9
34.1
235
920
H02AB04
ATC
methylprednisolone; systemic
2.8
33.9
244
982
I70.9
ICD-10 Finland
Generalized and unspecified atherosclerosis
8.0
32.8
76
100
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.2
32.7
436
2430
Z3226
NOMESCO Finland
Physiotherapist
2.6
32.6
275
1216
J01DB01
ATC
cefalexin; oral
2.1
32.2
935
7187
C07AB03
ATC
atenolol; systemic
4.9
32.0
110
242
A12AA12
ATC
[U] calcium acetate anhydrous; systemic
324.6
32.0
32
*
212
Kela drug reimbursment
Gout
7.9
31.9
74
98
C07FB02
ATC
metoprolol and felodipine; systemic
18.1
31.6
49
28
C09AA03
ATC
lisinopril; oral
7.6
31.3
75
104
C09AA05
ATC
ramipril; oral
2.3
31.0
361
1878
I13.2
ICD-10 Finland
Hypertensive heart and renal disease with both (congestive) heart failure and renal failure
320.2
31.0
31
*
JN3AD
NOMESCO Finland
Abdominal CT examination
3.9
30.7
136
382
C09CA07
ATC
telmisartan; oral
5.2
30.7
99
203
E87.5
ICD-10 Finland
Hyperkalaemia
12.1
30.6
56
48
C02LM02
ATC
NA
309.2
29.9
30
*
J01MA02
ATC
ciprofloxacin; systemic
2.0
29.4
543
3430
C02DE02
ATC
NA
9.5
29.4
61
67
C09DA03
ATC
valsartan and diuretics; oral
8.3
29.4
66
83
AN1
HP
Coronary angiography
2.8
29.2
206
814
A10BB12
ATC
glimepiride; oral
3.7
28.9
133
386
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
6.2
28.8
80
137
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.7
28.6
216
889
M10
ICD-10 Finland
Gout
4.9
28.6
98
215
C02DE04
ATC
NA
7.0
28.6
72
108
H02AB06
ATC
prednisolone; systemic
2.0
28.1
589
3886
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.2
28.1
356
1914
A02BC02
ATC
pantoprazole; systemic
1.9
28.1
773
5646
R4110
NOMESCO Finland
Physiotherapy
2.2
27.9
349
1865
PB1DE
NOMESCO Finland
Upper extremity arteries ultrasound examination with Doppler method
79.4
27.9
31
*
PC5DE
NOMESCO Finland
Ultrasound of kidney circulation with Doppler technic
287.4
27.8
28
*
I70.1
ICD-10 Finland
Atherosclerosis of renal artery
35.9
27.5
35
10
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.2
27.3
107
269
TJA33
NOMESCO Finland
Percutaneous introduction of peritoneal dialysis catheter
+∞
27.2
26
*
I13.1
ICD-10 Finland
Hypertensive heart and renal disease with renal failure
+∞
27.2
26
*
Q61.2
ICD-10 Finland
Polycystic kidney, autosomal dominant
+∞
27.2
26
*
N39.1
ICD-10 Finland
Persistent proteinuria, unspecified
21.1
26.6
39
19
B01AB10
ATC
tinzaparin; parenteral
4.0
26.5
112
301
J01FF01
ATC
clindamycin; systemic
2.2
26.4
330
1754
C10AX09
ATC
ezetimibe; oral
3.1
26.0
157
558
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
2.1
25.9
353
1946
A10AE05
ATC
insulin detemir; parenteral
5.3
25.4
80
160
I20.09
ICD-10 Finland
Unstable angina
3.6
25.3
121
362
E66.01
ICD-10 Finland
Obesity due to excess calories
6.5
25.3
67
108
UJF32
NOMESCO Finland
Coloscopy
2.1
25.2
350
1944
XF400
NOMESCO Finland
ECG with 12 standard connections
2.3
25.1
268
1318
C09AA01
ATC
captopril; oral
7.2
24.9
61
88
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.1
24.9
148
521
C08CA10
ATC
nilvadipine; oral
15.1
24.8
41
28
PBM10
NOMESCO Finland
Closure of arteriovenous fistula of radial artery
254.8
24.7
25
*
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
2.0
24.4
380
2206
SPAT1263
SPAT
Sampling
1.9
24.2
486
3108
SPAT1254
SPAT
Administration of medicine
2.5
23.9
215
969
L28
ICPC
Limited function/disability (L)
2.4
23.9
229
1065
M10.0
ICD-10 Finland
Idiopathic gout
6.2
23.8
65
109
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
4.2
23.8
94
238
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
6.0
23.7
66
114
Z2446
NOMESCO Finland
Social worker
3.8
23.4
104
293
Z01.8
ICD-10 Finland
Other specified special examinations
2.2
23.3
263
1324
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.7
23.1
177
727
I35.0
ICD-10 Finland
Aortic (valve) stenosis
3.4
23.1
116
360
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.4
23.1
227
1070
PBU84
NOMESCO Finland
Plastic repair of arteriovenous fistula from artery of upper extremity
+∞
23.0
22
*
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
2.9
23.0
150
561
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
3.4
22.9
115
357
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
4.4
22.8
84
199
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
22.7
457
2907
N02AX02
ATC
tramadol; systemic, rectal
1.8
22.6
527
3523
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
5.2
22.6
71
142
WX882
NOMESCO Finland
High dependency care
6.1
22.1
61
104
PG5AC
NOMESCO Finland
Contrast examination of injection gate to artery or vein
+∞
21.9
21
*
C07AB08
ATC
celiprolol; oral
7.0
21.4
53
78
C09BA03
ATC
lisinopril and diuretics; oral
14.2
21.4
36
26
A10BH02
ATC
vildagliptin; oral
8.6
21.2
46
55
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
3.3
21.2
111
356
R50.9
ICD-10 Finland
Fever, unspecified
2.4
21.2
196
893
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
7.5
21.1
50
69
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.4
21.1
190
854
I21.41
ICD-10 Finland
Acute subendocardial infarction stenosed coronary artery
4.0
21.0
87
230
ZXE20
NOMESCO Finland
More than three and less than five hours
2.4
20.9
200
927
WX203
NOMESCO Finland
Infraclavicular plexus blockade
6.3
20.9
56
92
WX892
NOMESCO Finland
Monitored bed care
3.1
20.7
118
402
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.1
20.7
119
409
3025
Kela drug reimbursment
Calcium carbonate
213.2
20.6
21
*
N26
ICD-10 Finland
Unspecified contracted kidney
213.2
20.6
21
*
N25.0
ICD-10 Finland
Renal osteodystrophy
213.2
20.6
21
*
N08.2
ICD-10 Finland
Glomerular disorders in blood diseases and disorders involving the immune mechanism
213.2
20.6
21
*
I50.1
ICD-10 Finland
Left ventricular failure
3.2
20.6
111
364
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.2
20.5
113
376
J01CA04
ATC
amoxicillin; systemic
1.8
20.5
871
6969
C02EA03
ATC
NA
33.1
20.2
26
8
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
2.9
20.2
130
481
J01MA12
ATC
levofloxacin; systemic
2.1
20.1
268
1444
SPAT1104
SPAT
Monitoring of emergency patient
3.2
20.0
109
360
SPAT1255
SPAT
Intravenous administration of medicine
3.4
20.0
100
310
ZXA05
NOMESCO Finland
Left side
1.9
20.0
350
2098
BBA40
NOMESCO Finland
Subtotal parathyroidectomy
58.5
19.9
23
*
TK824
NOMESCO Finland
Replacement of peritoneal dialysis catheter extension tube
+∞
19.8
19
*
C09DB01
ATC
valsartan and amlodipine; oral
8.2
19.8
44
55
A28
ICPC
Limited function/disability NOS
2.1
19.7
241
1249
N18.3
ICD-10 Finland
Chronic kidney disease, stage 3
202.9
19.6
20
*
PB1BC
NOMESCO Finland
Extensive angiography of upper extremity with X-ray
202.9
19.6
20
*
L04AX01
ATC
azathioprine; systemic
4.5
19.6
71
166
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
40.7
19.5
24
6
I25.2
ICD-10 Finland
Old myocardial infarction
2.7
19.5
146
590
E66.8
ICD-10 Finland
Other obesity
8.0
19.4
44
57
D63.8
ICD-10 Finland
Anaemia in other chronic diseases classified elsewhere
26.5
19.2
26
10
K87
ICPC
Hypertension complicated
6.7
19.1
49
76
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.3
19.0
194
925
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
5.3
18.8
58
114
7151
FHL
Kidney transplantation
+∞
18.8
18
*
58200
ICD-8 Finland
Chronic nephritis, Cum uraemia
+∞
18.8
18
*
FM1LE
NOMESCO Finland
Combined ultrasound and EKG examination of heart with tolerance test
28.3
18.8
25
9
C08CA03
ATC
isradipine; systemic
28.3
18.8
25
9
58209
ICD-8 Finland
Chronic nephritis, Unspecified
70.9
18.7
21
*
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.9
18.7
345
2095
C02EA01
ATC
NA
9.5
18.7
38
41
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
6.6
18.7
48
75
A02BC01
ATC
omeprazole; systemic
1.9
18.5
360
2231
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.1
18.4
226
1170
XF402
NOMESCO Finland
ECG with work load test
2.6
18.4
149
628
WX002
NOMESCO Finland
Sedation and analgesia
2.0
18.4
256
1398
A41.9
ICD-10 Finland
Sepsis, unspecified
3.8
18.2
78
213
G47.3
ICD-10 Finland
Sleep apnoea
2.2
18.0
207
1041
D89.80
ICD-10 Finland
Immunoglobulin A (IgA) deposits in organisms
+∞
17.7
17
*
K78
ICPC
Atrial fibrillation/flutter
2.7
17.7
131
527
PC5CG
NOMESCO Finland
Extensive MRI examination of kidney vasculature with high intensity magnet
182.3
17.5
18
*
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.7
17.5
480
3305
R60.0
ICD-10 Finland
Localized oedema
2.5
17.5
147
634
N11.9
ICD-10 Finland
Chronic tubulo-interstitial nephritis, unspecified
29.2
17.4
23
8
K65.9
ICD-10 Finland
Peritonitis, unspecified
24.4
17.3
24
10
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.2
17.3
198
993
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
2.5
17.3
149
652
S97
ICPC
Chronic ulcer skin
3.4
17.3
86
266
N04.9
ICD-10 Finland
Nephrotic syndrome, unspecified
31.9
17.1
22
7
XPX08
NOMESCO Finland
Intraoperative flow measurement
13.5
17.0
29
22
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
4.7
16.9
58
129
SPAT1097
SPAT
Recording of ECG
2.1
16.8
197
999
ZXA00
NOMESCO Finland
Right side
1.8
16.8
355
2250
PD4CG
NOMESCO Finland
Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet
9.0
16.7
35
40
D638, N180
ICD-10 Finland
NA
+∞
16.7
16
*
40299
ICD-8 Finland
Hypertensive heart disease
+∞
16.7
16
*
PB1AC
NOMESCO Finland
Angiography of upper extremity with X-ray
+∞
16.7
16
*
4029A
ICD-9 Finland
Hypertensive heart disease, Unspecified[DECOMPENSATIO CORDIS NON INDICATA (WHO II)]
+∞
16.7
16
*
M04AA03
ATC
febuxostat; oral
35.5
16.7
21
6
349
Kela drug reimbursment
Febuxostat
40.6
16.3
20
5
PG1XE
NOMESCO Finland
Other ultrasound examination of blood vessel not elsewhere classified
40.6
16.3
20
5
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
8.5
16.3
35
42
K92.1
ICD-10 Finland
Melaena
3.1
16.2
92
312
288
Kela drug reimbursment
Febuxostat
30.4
16.1
21
7
I20.99
ICD-10 Finland
Angina pectoris, unspecified
2.7
16.1
115
454
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
6.6
16.0
41
64
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
6.6
16.0
41
64
K65.8
ICD-10 Finland
Other peritonitis
48.1
16.0
19
*
C07AB05
ATC
betaxolol; oral
6.1
16.0
43
72
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.4
15.9
147
665
N04.1
ICD-10 Finland
Nephrotic syndrome, focal and segmental glomerular lesions
60.8
15.8
18
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.4
15.7
134
583
ZST00
NOMESCO Finland
Procedure related to previous procedure classified in chapter T
+∞
15.6
15
*
6112
FHL
Installation of a peritoneal dialysis or lavage catheter in an operating room
+∞
15.6
15
*
WX202
NOMESCO Finland
Supraclavicular plexus blockade
8.0
15.6
35
45
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
26.6
15.6
21
8
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.5
15.5
127
541
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
2.7
15.5
107
413
SPAT1211
SPAT
Application of soft bandage
2.6
15.5
121
503
R55
ICD-10 Finland
Syncope and collapse
2.2
15.5
161
770
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.0
15.3
228
1268
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
4.1
15.3
60
152
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
7.4
15.3
36
50
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.9
15.3
95
344
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
4.2
15.2
58
143
C09DA07
ATC
telmisartan and diuretics; oral
5.4
15.2
45
85
TKC20
NOMESCO Finland
Catheterisation of bladder
2.5
15.2
122
514
A10AD05
ATC
insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
6.7
15.1
38
58
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.5
15.1
119
496
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
15.1
402
2713
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
3.0
15.1
88
306
J01DA01
ATC
[U] cefalexin; systemic
1.6
15.0
707
5563
XCK10
NOMESCO Finland
Photography of fundus of eye
2.4
14.9
134
598
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
3.1
14.8
84
285
PC5SC
NOMESCO Finland
Selective angiography of kidney artery with X-ray
57.3
14.8
17
*
T92
ICPC
Gout
6.2
14.8
39
64
N17.8
ICD-10 Finland
Other acute renal failure
8.8
14.8
31
36
Z3229
NOMESCO Finland
Other healthcare associate professional
2.4
14.7
126
548
4059X
ICD-9 Finland
Secondary hypertension, Unspecified[HYPERTONIA SECUNDARIA NUD]
+∞
14.6
14
*
Z99.2
ICD-10 Finland
Dependence on renal dialysis
+∞
14.6
14
*
H05BX02
ATC
paricalcitol; systemic
+∞
14.6
14
*
PC5YT
NOMESCO Finland
Stenting of renal artery
151.6
14.5
15
*
Q61.3
ICD-10 Finland
Polycystic kidney, unspecified
151.6
14.5
15
*
SPAT1229
SPAT
Assessment of need for aid
2.5
14.4
114
476
160
Kela drug reimbursment
exenatide
17.2
14.3
22
13
E83.51
ICD-10 Finland
Hypocalcemia
22.5
14.2
20
9
E11
ICD-10 Finland
Type 2 diabetes mellitus
2.2
14.0
157
778
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.0
14.0
82
286
PD4AC
NOMESCO Finland
Arterigography of lower extremity with X-ray
9.0
14.0
29
33
C07AB12
ATC
nebivolol; oral
5.8
14.0
39
69
TFP20
NOMESCO Finland
Cardiodefibrillation
2.6
13.9
105
427
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.7
13.9
60
166
Z2221
NOMESCO Finland
Medical doctor
1.7
13.9
313
2004
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.6
13.9
101
402
A04
ICPC
Weakness/tiredness general
2.2
13.9
155
764
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
3.3
13.8
70
221
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
5.2
13.7
42
83
WX110
NOMESCO Finland
Local anesthesy
1.6
13.7
665
5221
SPAT1249
SPAT
Treatment-related counselling outside office
1.6
13.7
407
2821
E78.29
ICD-10 Finland
Other mixed hyperlipidaemia
12.2
13.6
24
20
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.0
13.6
176
926
G63.8*N18.8
ICD-10 Finland
Uraemic neuropathy
75.9
13.6
15
*
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
4.6
13.6
47
106
4059A
ICD-9 Finland
Secondary hypertension, Unspecified[HYPERTONIA RENOVASCULARIS]
+∞
13.6
13
*
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
5.3
13.5
41
80
JA3FT
NOMESCO Finland
Exchange abdominal catheter with radiological guidance
141.4
13.5
14
*
WW500
NOMESCO Finland
Blood transfusion
3.2
13.5
70
225
N17.0
ICD-10 Finland
Acute renal failure with tubular necrosis
13.0
13.4
23
18
RS220
NOMESCO Finland
NA
8.2
13.3
29
36
A10BB01
ATC
glibenclamide; oral
2.9
13.3
82
296
C03EA02
ATC
trichlormethiazide and potassium-sparing agents; oral
7.4
13.3
31
43
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
3.6
13.3
60
173
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
13.3
295
1875
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.1
13.2
72
240
TQW80
NOMESCO Finland
Local dermatologic skincare
4.7
13.2
44
96
XF404
NOMESCO Finland
Ambulatory ECG
2.3
13.0
119
535
M01AB01
ATC
indometacin; systemic, rectal
2.3
13.0
126
581
C10AA03
ATC
pravastatin; oral
2.5
13.0
100
412
I50
ICD-10 Finland
Heart failure
3.5
12.9
59
172
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
2.7
12.8
87
333
JN4AD
NOMESCO Finland
Body CT examination
2.4
12.8
109
473
B01AB05
ATC
enoxaparin; parenteral
1.7
12.8
338
2261
C07BB07
ATC
bisoprolol and thiazides; systemic
4.7
12.7
42
91
E87.6
ICD-10 Finland
Hypokalaemia
5.1
12.7
39
78
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
6.2
12.6
33
54
N03AX16
ATC
pregabalin; oral
1.8
12.6
239
1445
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
5.6
12.6
36
66
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
4.5
12.6
44
101
5850B
ICD-9 Finland
Chronic renal failure[INSUFFICIENTIA RENIS CHRONICA CUM URAEMIA]
+∞
12.5
12
*
N03.8
ICD-10 Finland
Chronic nephritic syndrome, other
+∞
12.5
12
*
5828A
ICD-9 Finland
Chronic glomerulonephritis, With other specified pathological lesion in kidney[GLOMERULONEPHRITIS CHRONICA ALIA DEF,EI NEFR SDR]
+∞
12.5
12
*
4059B
ICD-9 Finland
Secondary hypertension, Unspecified[HYPERTONIA SECUNDARIA ALIA DEFINITA]
+∞
12.5
12
*
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
6.4
12.5
32
51
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
2.4
12.5
110
486
D638, N189
ICD-10 Finland
NA
131.2
12.5
13
*
N06.9
ICD-10 Finland
Isolated proteinuria with specified morphological lesion, unspecified
131.2
12.5
13
*
I20.89
ICD-10 Finland
Other angina pectoris unspecified coronary artery status
2.9
12.3
73
258
WX204
NOMESCO Finland
Axillary plexus blockaced
4.0
12.2
48
123
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.6
12.2
462
3384
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
2.8
12.2
79
294
K86
ICPC
Hypertension uncomplicated
2.3
12.1
115
528
I71.4
ICD-10 Finland
Abdominal aortic aneurysm, without mention of rupture
3.4
12.1
57
171
A10BJ06
ATC
semaglutide; parenteral
6.6
12.1
30
46
L01BB01
ATC
NA
21.5
12.0
17
8
KBV00
NOMESCO Finland
Insertion of stent into ureter
9.4
12.0
24
26
WX872
NOMESCO Finland
Intensive care
2.9
12.0
71
251
ZXE00
NOMESCO Finland
One hour or less
1.6
11.8
427
3084
C09DX01
ATC
valsartan, amlodipine and hydrochlorothiazide; oral
11.8
11.8
21
18
R31
ICD-10 Finland
Unspecified haematuria
2.0
11.7
156
831
R53
ICD-10 Finland
Malaise and fatigue
1.8
11.7
229
1396
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
2.4
11.6
99
430
81
HP
Angiography of the heart and coronary arteries
2.2
11.6
119
564
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.6
11.6
355
2457
E21.1
ICD-10 Finland
Secondary hyperparathyroidism, not elsewhere classified
23.1
11.6
16
7
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.5
11.6
472
3510
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
4.1
11.5
44
110
KA9AE
NOMESCO Finland
Ultrasound examination transplanted kidney
+∞
11.5
11
*
PB1AT
NOMESCO Finland
Upper extremity artery PTA
+∞
11.5
11
*
E78.9
ICD-10 Finland
Disorder of lipoprotein metabolism, unspecified
3.7
11.4
49
136
75310
ICD-8 Finland
Congenital anomalies of urinary system, Ren polycysticus bilateralis
121.0
11.4
12
*
N03.3
ICD-10 Finland
Chronic nephritic syndrome, diffuse mesangial proliferative glomerulonephritis
121.0
11.4
12
*
XW000
NOMESCO Finland
Bone marrow biopsy
3.0
11.4
67
235
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.6
11.4
86
351
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
6.1
11.4
30
50
E83.50
ICD-10 Finland
Hypercalcemia
7.0
11.4
27
39
FNA01
NOMESCO Finland
Anastomosis to coronary artery from internal mammary artery, one distal anastamosis
2.7
11.3
76
290
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
4.0
11.3
44
112
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.4
11.3
94
404
N18.4
ICD-10 Finland
Chronic kidney disease, stage 4
35.3
11.3
14
*
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
9.0
11.3
23
26
A10BJ02
ATC
liraglutide; parenteral
9.7
11.3
22
23
K85
ICPC
Elevated blood pressure
2.0
11.2
151
806
I65.2
ICD-10 Finland
Occlusion and stenosis of carotid artery
4.6
11.2
38
85
PE1AT
NOMESCO Finland
Femoral artery PTA
6.9
11.2
27
40
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.4
11.1
97
428
R07.4
ICD-10 Finland
Chest pain, unspecified
1.7
11.1
291
1933
H35.0
ICD-10 Finland
Background retinopathy and retinal vascular changes
14.0
11.0
18
13
PWE00
NOMESCO Finland
Reoperation for deep haemorrhage in surgery of peripheral vessels and lymphatic system
14.0
11.0
18
13
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.6
10.9
77
303
UJF92
NOMESCO Finland
Capsular endoscopy
6.0
10.9
29
49
SPAT1216
SPAT
Assessment of functional ability
1.8
10.9
198
1176
Z95.5
ICD-10 Finland
Presence of coronary angioplasty implant and graft
3.2
10.9
56
180
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
3.6
10.9
48
137
B82
ICPC
Anaemia other/unspecified
4.0
10.8
42
107
A41.8
ICD-10 Finland
Other specified sepsis
5.1
10.8
33
66
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.8
10.7
190
1117
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
3.8
10.7
45
123
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
2.7
10.7
75
293
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.6
10.7
300
2022
B01AF02
ATC
apixaban; oral
2.1
10.7
126
635
63701
ICD-8 Finland
Pre-eclampsia, eclampsia and toxaemia, unspecified, Hypertonia
13.0
10.7
18
14
J96.0
ICD-10 Finland
Acute respiratory failure
6.4
10.6
27
43
V03AE04
ATC
calcium acetate and magnesium carbonate; systemic
60.5
10.6
12
*
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
4.8
10.6
34
72
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.8
10.6
189
1117
R11
ICD-10 Finland
Nausea and vomiting
2.4
10.5
87
373
Y0399
ICD-8 Finland
Investigation of circulatory system
5.1
10.5
32
64
I80.1
ICD-10 Finland
Phlebitis and thrombophlebitis of femoral vein
5.5
10.4
30
56
I20.00
ICD-10 Finland
Unstable angina
2.9
10.4
61
214
C02DE12
ATC
NA
110.8
10.4
11
*
J12.0
ICD-10 Finland
Adenoviral pneumonia
110.8
10.4
11
*
T86.1
ICD-10 Finland
Kidney transplant failure and rejection
+∞
10.4
10
*
7531A
ICD-9 Finland
Congenital anomalies of urinary system, Cystic kidney disease
+∞
10.4
10
*
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
+∞
10.4
10
*
177
Kela drug reimbursment
Insulin glargine 300 U / ml
6.9
10.4
25
37
I21.99
ICD-10 Finland
Myocardial infarction (acute) UNS unspecified coronary artery status
3.0
10.4
59
202
TQW99
NOMESCO Finland
Other minor procedure on skin
2.6
10.4
74
294
SPAT1252
SPAT
Overall medication plan or its review
2.3
10.4
94
423
NHQ40
NOMESCO Finland
Amputation of toe
5.6
10.3
29
53
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.9
10.2
167
955
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.6
10.2
72
284
H3603, E113
ICD-10 Finland
NA
13.2
10.2
17
13
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
6.0
10.1
27
46
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.2
10.1
109
529
SPAT1099
SPAT
Measurement of blood pressure with Doppler ultrasound device
3.5
10.1
45
130
A08
ICPC
Swelling
3.0
10.1
58
201
207
Kela drug reimbursment
Chronic arrhythmias
1.8
10.1
191
1149
J01MA14
ATC
moxifloxacin; systemic
2.1
10.1
111
546
UKC02
NOMESCO Finland
Cystoscopy
1.7
10.0
239
1537
R4180
NOMESCO Finland
Podiatric therapy
9.2
10.0
20
22
E26.0
ICD-10 Finland
Primary hyperaldosteronism
40.4
10.0
12
*
XF600
NOMESCO Finland
Bloodpressure measurement
2.4
9.9
80
339
J01CA08
ATC
pivmecillinam; oral
1.6
9.9
311
2157
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.1
9.8
52
171
S18
ICPC
Laceration/cut
1.5
9.8
455
3444
N11.8
ICD-10 Finland
Other chronic tubulo-interstitial nephritis
26.2
9.8
13
5
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.7
9.8
67
260
SPAT1301
SPAT
No procedures
1.6
9.7
340
2416
SPAT1100
SPAT
Long-term monitoring of blood pressure
2.3
9.7
90
410
A07AA09
ATC
vancomycin; oral
6.2
9.7
25
41
PD3YT
NOMESCO Finland
Pelvic artery PTA with stent
6.2
9.7
25
41
59328
ICD-8 Finland
Other diseases of kidney and ureter, Morbi renis alii
55.4
9.7
11
*
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
3.9
9.6
38
99
B99
ICD-10 Finland
Other and unspecified infectious diseases
3.8
9.6
39
104
FN1BT
NOMESCO Finland
Extensive endovascular dilatation of coronary (PTCA) arteries
3.8
9.6
39
104
A10BX01
ATC
guar gum; systemic
3.0
9.6
55
189
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
4.3
9.6
34
80
R02
ICPC
Shortness of breath/dyspnoea
2.0
9.6
131
704
N02AJ06
ATC
codeine and paracetamol; systemic
1.6
9.5
326
2305
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
5.7
9.5
26
46
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.8
9.5
166
970
ZXD10
NOMESCO Finland
Scheduled procedure
1.5
9.5
428
3218
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.7
9.5
40
111
SPAT1325
SPAT
Vaccination
1.5
9.4
397
2940
N05CD07
ATC
temazepam; oral
1.7
9.4
190
1163
PAF14
NOMESCO Finland
Thrombendarterectomy of internal carotid artery
5.2
9.4
28
55
N28.9
ICD-10 Finland
Disorder of kidney and ureter, unspecified
30.2
9.4
12
*
-50
ICPC
Medication/prescr/renewal
2.7
9.4
61
230
I13.9
ICD-10 Finland
Hypertensive heart and renal disease, unspecified
+∞
9.4
9
*
5829A
ICD-9 Finland
Chronic glomerulonephritis with unspecified pathological lesion in kidney[GLOMERULONEPHRITIS CHRONICA NUD ,EI NEFR SDR]
+∞
9.4
9
*
JAL10
NOMESCO Finland
Laparotomy and removal of foreign body
+∞
9.4
9
*
PBM09
NOMESCO Finland
Closure of arteriovenous fistula of brachial artery
+∞
9.4
9
*
5602
FHL
Internal fistula (eg Cimino)
+∞
9.4
9
*
N0832, E112
ICD-10 Finland
NA
+∞
9.4
9
*
PC6DE
NOMESCO Finland
NA
+∞
9.4
9
*
PC5AT
NOMESCO Finland
Kidney artery PTA
+∞
9.4
9
*
I13.0
ICD-10 Finland
Hypertensive heart and renal disease with (congestive) heart failure
+∞
9.4
9
*
ZY010
NOMESCO Finland
Hospital outpatient
3.7
9.4
40
112
RJ410
NOMESCO Finland
NA
21.9
9.4
13
6
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
8.7
9.3
19
22
N05CF01
ATC
zopiclone; oral
1.5
9.3
377
2769
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
5.5
9.2
26
48
E66.9
ICD-10 Finland
Obesity, unspecified
5.8
9.2
25
44
L03.0
ICD-10 Finland
Cellulitis of finger and toe
2.5
9.2
70
289
TPX15
NOMESCO Finland
Removal of vascular injection port
13.8
9.2
15
11
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
3.4
9.1
42
125
WX402
NOMESCO Finland
General anaesthesia
1.9
9.1
145
822
E78.00
ICD-10 Finland
Familial hypercholesterolaemia
3.2
9.1
45
142
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
11.5
9.1
16
14
H3603, E103
ICD-10 Finland
NA
11.5
9.1
16
14
K07
ICPC
Swollen ankles/oedema
2.8
9.0
57
210
H3601, E113
ICD-10 Finland
NA
7.1
9.0
21
30
C07AG01
ATC
labetalol; systemic
36.9
9.0
11
*
FN1YT
NOMESCO Finland
Percutaneous insertion of coronary artery stent
2.3
9.0
82
370
PG1AE
NOMESCO Finland
Ultrasound examination of artery not elsewher classified
18.7
8.9
13
7
L17
ICPC
Foot/toe symptom/complaint
1.6
8.9
240
1596
C44.62
ICD-10 Finland
Spinocellular carcinoma of the skin of the upper extremity including the shoulder
12.6
8.9
15
12
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
3.9
8.9
35
92
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.0
8.8
117
622
H34.2
ICD-10 Finland
Other retinal artery occlusions
8.7
8.8
18
21
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.2
8.8
45
146
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
8.8
320
2290
FN1AT
NOMESCO Finland
Endovascular dilatation of coronary arteries (PTCA)
2.4
8.7
75
328
2503B
ICD-9 Finland
Diabetes mellitus, Diabetes with other coma[SOKERITAUDIN AIHEUTTAMA MUNUAISSAIRAUS,TYYPPI I]
50.3
8.7
10
*
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.9
8.7
136
766
GD1AD
NOMESCO Finland
Thorax CT examination
2.7
8.6
59
229
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
3.0
8.6
47
159
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.6
8.6
228
1509
A10AA02
ATC
NA
3.4
8.6
40
121
KAC00
NOMESCO Finland
Nephrectomy
16.4
8.6
13
8
E21.2
ICD-10 Finland
Other hyperparathyroidism
16.4
8.6
13
8
11
HP
Coronary artery bypass surgery
3.0
8.5
49
170
PE1BT
NOMESCO Finland
Femoral artery extensive PTA
9.0
8.5
17
19
R5140
NOMESCO Finland
Monitoring the use of the aid
2.0
8.5
104
532
25002
ICD-8 Finland
Diabetes mellitus, Retinopathia diabetica
20.2
8.5
12
6
N02AA05
ATC
oxycodone; systemic
1.7
8.4
192
1216
Z94.9
ICD-10 Finland
Transplanted organ and tissue status, unspecified
90.6
8.4
9
*
H3600, E113
ICD-10 Finland
NA
6.7
8.4
20
30
N03.1
ICD-10 Finland
Chronic nephritic syndrome, focal and segmental glomerular lesions
+∞
8.3
8
*
PBC09
NOMESCO Finland
Suture of brachial artery
+∞
8.3
8
*
PC5BG
NOMESCO Finland
MRI examination of kidney vasculature with high intensity magnet
+∞
8.3
8
*
PC5BT
NOMESCO Finland
Kideney artery extensive PTA
+∞
8.3
8
*
5850A
ICD-9 Finland
Chronic renal failure[INSUFFICIENTIA RENIS CHRONICA SINE URAEMIA]
+∞
8.3
8
*
4040A
ICD-9 Finland
Hypertensive heart and renal disease, Malignant
+∞
8.3
8
*
-45
ICPC
Observ/health educat/advice/diet
3.3
8.3
40
124
NFQ20
NOMESCO Finland
Amputation of femur
5.6
8.3
23
42
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
2.5
8.3
66
277
K25.9
ICD-10 Finland
Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation
4.0
8.3
31
78
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
3.2
8.3
41
130
A10AA01
ATC
NA
4.4
8.3
28
64
J01CF05
ATC
flucloxacillin; systemic
3.2
8.2
42
136
I48.1
ICD-10 Finland
Persistent atrial fibrillation
3.5
8.2
37
109
E86
ICD-10 Finland
Volume depletion
3.3
8.2
39
120
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
2.3
8.2
74
333
K55.0
ICD-10 Finland
Acute vascular disorders of intestine
7.6
8.2
18
24
XQ848
NOMESCO Finland
Dermatological photography
3.2
8.2
40
126
PEF23
NOMESCO Finland
Thrombendarterectomy of femoral artery
4.7
8.1
26
56
K05.31
ICD-10 Finland
Periodontitis pronounced
2.0
8.1
101
522
K06.18
ICD-10 Finland
Another gingival hyperplasia
17.3
8.1
12
7
SPAT1304
SPAT
Counselling and guidance related to ageing
2.0
8.1
101
525
C10AA07
ATC
rosuvastatin; oral
1.6
8.1
227
1524
SPAT1294
SPAT
Other function in accordance with health social work nomenclature
3.4
8.1
37
111
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
22.2
8.0
11
5
A10BX04
ATC
[U] exenatide; parenteral
22.2
8.0
11
5
N05BA01
ATC
diazepam; systemic, rectal
1.8
8.0
148
882
I70.0
ICD-10 Finland
Atherosclerosis of aorta
7.3
8.0
18
25
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
3.8
8.0
32
86
-48
ICPC
Clarification/discussion RFE/demand
3.8
8.0
32
86
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
2.6
7.9
55
217
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
3.3
7.9
37
113
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
13.1
7.9
13
10
E000006
ATC
NA
2.3
7.8
72
327
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.7
7.8
168
1048
WX610
NOMESCO Finland
Patient controlled analgesia
9.5
7.8
15
16
A02BC03
ATC
lansoprazole; oral
1.5
7.8
324
2379
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.5
7.7
60
250
M10.2
ICD-10 Finland
Drug-induced gout
15.1
7.7
12
8
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
45.2
7.7
9
*
I11
ICD-10 Finland
Hypertensive heart disease
45.2
7.7
9
*
D638, N188
ICD-10 Finland
NA
45.2
7.7
9
*
I21.40
ICD-10 Finland
Acute subendocardial infarction no detected stenosis of the coronary artery
2.8
7.7
46
166
A10BX02
ATC
repaglinide; oral
5.3
7.7
22
42
FPE00
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with ventricular electrode
3.2
7.7
38
121
R2110
NOMESCO Finland
Giving the first information
2.4
7.6
60
253
K28
ICPC
Limited function/disability (K)
4.2
7.6
27
65
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.7
7.6
52
201
58399
ICD-8 Finland
Nephritis, unqualified
25.1
7.6
10
*
M48.0
ICD-10 Finland
Spinal stenosis
1.8
7.6
139
825
E21.3
ICD-10 Finland
Hyperparathyroidism, unspecified
6.2
7.5
19
31
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
5.5
7.5
21
39
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
2.6
7.5
53
211
C09AA04
ATC
perindopril; oral
2.4
7.5
62
268
I15.8
ICD-10 Finland
Other secondary hypertension
80.5
7.4
8
*
N08.3
ICD-10 Finland
Glomerular disorders in diabetes mellitus
80.5
7.4
8
*
TJA30
NOMESCO Finland
Peritoneal dialysis
80.5
7.4
8
*
AA1
HP
Conventional CABG
3.5
7.4
32
92
T89
ICPC
Diabetes insulin dependent
3.5
7.4
32
92
PD1BD
NOMESCO Finland
Extensive CT of abdominal aorta and branches
5.3
7.4
21
40
PA6AE
NOMESCO Finland
Ulrasound examination of neck vasculature
6.0
7.4
19
32
M01AE01
ATC
ibuprofen; systemic, rectal
0.7
7.4
732
8310
EB1WA
NOMESCO Finland
NA
8.4
7.3
15
18
UJF30
NOMESCO Finland
Ileoscopy through colon
2.0
7.3
91
471
N30.0
ICD-10 Finland
Acute cystitis
1.8
7.3
132
781
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.9
7.3
42
147
44708
ICD-8 Finland
Other disease of arteries and arterioles, Alii definiti
+∞
7.3
7
*
187
Kela drug reimbursment
MPA
+∞
7.3
7
*
KAS20
NOMESCO Finland
Allogenic transplantation of kidney from living donor
+∞
7.3
7
*
L04AA05
ATC
[U] tacrolimus; systemic
+∞
7.3
7
*
C02DC01
ATC
minoxidil; oral
+∞
7.3
7
*
Z12.8
ICD-10 Finland
Special screening examination for neoplasms of other sites
+∞
7.3
7
*
9968A
ICD-9 Finland
Complications peculiar to certain specified procedures, Complications of transplanted organ
+∞
7.3
7
*
C02DB01
ATC
dihydralazine; systemic
+∞
7.3
7
*
4029B
ICD-9 Finland
Hypertensive heart disease, Unspecified[CUM DECOMPENSATIONE CORDIS (WHO III)]
+∞
7.3
7
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.5
7.3
307
2256
C07BB02
ATC
metoprolol and thiazides; systemic
9.4
7.3
14
15
RS222
NOMESCO Finland
NA
4.5
7.3
24
54
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
5.2
7.3
21
41
H26.2
ICD-10 Finland
Complicated cataract
5.2
7.3
21
41
I65.3
ICD-10 Finland
Occlusion and stenosis of multiple and bilateral precerebral arteries
15.8
7.2
11
7
78900
ICD-8 Finland
Abnormal urinary constituents of unspecified cause, Albuminuria
15.8
7.2
11
7
N28.1
ICD-10 Finland
Cyst of kidney
4.7
7.2
23
50
FN2BA
NOMESCO Finland
Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)
2.3
7.2
65
293
K92.0
ICD-10 Finland
Haematemesis
2.9
7.2
41
142
SPAT1139
SPAT
Nutrition survey
2.9
7.2
41
142
A06AD11
ATC
lactulose; oral
1.6
7.2
202
1352
R03AC02
ATC
salbutamol; inhalant
1.4
7.2
487
3913
WX730
NOMESCO Finland
Conventional respirator
4.4
7.2
24
55
C10AB02
ATC
bezafibrate; oral
4.4
7.2
24
55
C02EA05
ATC
NA
30.2
7.1
9
*
J45.9
ICD-10 Finland
Asthma, unspecified
1.7
7.1
166
1057
TJW99
NOMESCO Finland
Other minor procedure in gastrointestinal endoscopy
20.1
7.1
10
5
RJ210
NOMESCO Finland
NA
20.1
7.1
10
5
C09AA06
ATC
quinapril; systemic
20.1
7.1
10
5
RJ420
NOMESCO Finland
NA
20.1
7.1
10
5
WZC30
NOMESCO Finland
Teaching
1.8
7.1
129
765
NGQ20
NOMESCO Finland
Amputation of lower leg
8.0
7.1
15
19
H25.1
ICD-10 Finland
Senile nuclear cataract
1.4
7.1
369
2825
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.2
7.1
70
331
WNF00
NOMESCO Finland
Infection source and contact determination
12.1
7.1
12
10
AN3
HP
Balloon angioplasty and metallic stent
2.7
7.1
46
175
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.8
7.0
112
635
RJ411
NOMESCO Finland
NA
10.1
7.0
13
13
RJ421
NOMESCO Finland
NA
10.1
7.0
13
13
I48.2
ICD-10 Finland
Chronic atrial fibrillation
3.5
7.0
31
91
M79.6
ICD-10 Finland
Pain in limb
1.5
7.0
315
2343
I95.9
ICD-10 Finland
Hypotension, unspecified
4.2
7.0
25
61
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
2.0
7.0
85
439
TQW11
NOMESCO Finland
Vacuum treatment of wound
4.3
6.9
24
57
A10BG03
ATC
pioglitazone; oral
3.8
6.9
27
72
NF1AA
NOMESCO Finland
Hip X-ray examination
1.9
6.9
105
588
J94.8
ICD-10 Finland
Other specified pleural conditions
3.5
6.8
30
88
C09CA02
ATC
eprosartan; oral
6.7
6.8
16
24
ZPB40
NOMESCO Finland
Polytetrafluoroethylene
11.0
6.8
12
11
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.6
6.8
48
192
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.7
6.8
147
920
KBV10
NOMESCO Finland
Removal of stent from ureter
5.7
6.8
18
32
Z90.5
ICD-10 Finland
Acquired absence of kidney
40.2
6.8
8
*
5AB14
NOMESCO Finland
NA
40.2
6.8
8
*
C09DA02
ATC
eprosartan and diuretics; oral
16.8
6.7
10
6
A10BX07
ATC
[U] liraglutide; parenteral
16.8
6.7
10
6
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
6.7
177
1164
A08AB01
ATC
orlistat; oral
22.6
6.7
9
*
RD112
NOMESCO Finland
NA
22.6
6.7
9
*
N05.9
ICD-10 Finland
Unspecified nephritic syndrome, unspecified
22.6
6.7
9
*
I20.90
ICD-10 Finland
Angina pectoris, unspecified
2.4
6.7
54
233
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
2.4
6.6
53
225
I71.2
ICD-10 Finland
Thoracic aortic aneurysm, without mention of rupture
3.1
6.6
34
112
FNC30
NOMESCO Finland
Aorto-coronary venous bypass with three distal anastomoses
3.2
6.6
32
101
PEN23
NOMESCO Finland
Plastic repair of femoral artery
6.5
6.6
16
25
R04.0
ICD-10 Finland
Epistaxis
1.9
6.6
88
470
J01MA06
ATC
norfloxacin; oral
1.7
6.6
145
907
K77
ICPC
Heart failure
3.3
6.6
31
96
-34
ICPC
Blood test
2.9
6.6
38
134
I63.0
ICD-10 Finland
Cerebral infarction due to thrombosis of precerebral arteries
3.9
6.6
25
65
C07AB04
ATC
acebutolol; systemic
3.9
6.6
25
65
I35.2
ICD-10 Finland
Aortic (valve) stenosis with insufficiency
2.8
6.5
40
148
M18.9
ICD-10 Finland
Arthrosis of first carpometacarpal joint, unspecified
4.8
6.5
20
42
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.0
6.5
81
421
SPAT1234
SPAT
Support of social functional capacity
2.1
6.5
66
317
A10AE06
ATC
insulin degludec; parenteral
4.0
6.5
24
61
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
2.4
6.5
52
222
XCD10
NOMESCO Finland
Electrophysiological examination of eye
3.0
6.5
35
120
PH2CD
NOMESCO Finland
Very extensive CT of inferior vena cava, pelvic veins and veins of lower extremity
6.2
6.5
16
26
D04.7
ICD-10 Finland
Carcinoma in situ: Skin of lower limb, including hip
6.2
6.5
16
26
R51.80
ICD-10 Finland
Headache
1.8
6.5
102
579
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.1
6.5
70
345
I25.5
ICD-10 Finland
Ischaemic cardiomyopathy
3.1
6.4
33
109
75302
ICD-8 Finland
Congenital anomalies of urinary system, Hypoplasia et dysplasia renis
70.1
6.4
7
*
PBU99
NOMESCO Finland
Other repair after previous reconstruction of arteries of upper extremity
70.1
6.4
7
*
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
1.6
6.4
168
1106
H36.01
ICD-10 Finland
Diabetic maculopathy
7.4
6.4
14
19
H26.3
ICD-10 Finland
Drug-induced cataract
7.4
6.4
14
19
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
3.6
6.4
27
77
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
2.2
6.4
62
289
162
Kela drug reimbursment
liraglutide
14.4
6.4
10
7
2500A
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]
2.6
6.4
43
169
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
6.4
451
3631
WX144
NOMESCO Finland
Subconjunctival anesthesy
4.4
6.4
21
48
C01BD01
ATC
amiodarone; systemic
2.7
6.3
41
155
E66.0
ICD-10 Finland
Obesity due to excess calories
8.2
6.3
13
16
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.5
6.3
45
181
A10BB07
ATC
glipizide; oral
3.6
6.3
26
73
A49.0
ICD-10 Finland
Staphylococcal infection, unspecified site
11.1
6.3
11
10
D89.8
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
+∞
6.3
6
*
RJ425
NOMESCO Finland
NA
+∞
6.3
6
*
SPAT1164
SPAT
Haemodialysis
+∞
6.3
6
*
B05D
ATC
PERITONEAL DIALYTICS
+∞
6.3
6
*
44010
ICD-8 Finland
Arteriosclerosis, Of renal artery
+∞
6.3
6
*
I15.2
ICD-10 Finland
Hypertension secondary to endocrine disorders
+∞
6.3
6
*
I21.97
ICD-10 Finland
Suspected acute myocardial infarction
4.3
6.2
21
49
G40.9
ICD-10 Finland
Epilepsy, unspecified
2.6
6.2
42
165
C09BA04
ATC
perindopril and diuretics; systemic
4.8
6.2
19
40
GD2SN
NOMESCO Finland
Lung ventilation SPECT
7.1
6.2
14
20
I49.5
ICD-10 Finland
Sick sinus syndrome
2.3
6.2
54
242
I20.01
ICD-10 Finland
Unstable angina
2.6
6.2
44
176
I21.90
ICD-10 Finland
Myocardial infarction (acute) UNS no detected stenosis of the coronary artery
2.9
6.2
36
128
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
4.1
6.2
22
54
H03AA01
ATC
levothyroxine sodium; systemic
1.5
6.2
200
1384
SPAT1260
SPAT
Consultation of another employee
1.6
6.2
170
1132
C01AA05
ATC
digoxin; systemic
1.7
6.2
135
848
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
2.3
6.1
51
224
B03BA03
ATC
hydroxocobalamin; parenteral
1.9
6.1
80
424
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
2.8
6.1
36
130
CKC12
NOMESCO Finland
Photocoagulation of retina
2.5
6.1
45
186
R00.1
ICD-10 Finland
Bradycardia, unspecified
2.5
6.1
44
179
D07AC01
ATC
betamethasone; topical
1.4
6.1
336
2586
E0000UV
ATC
NA
1.4
6.1
367
2871
EBA00
NOMESCO Finland
Extraction of tooth
1.4
6.1
284
2119
R60.9
ICD-10 Finland
Oedema, unspecified
2.4
6.1
47
199
59000
ICD-8 Finland
Infections of kidney, Pyelonephritis chronica
8.6
6.1
12
14
E000001
ATC
NA
1.5
6.1
187
1278
C09BA05
ATC
ramipril and diuretics; oral
4.4
6.0
20
46
K42.9
ICD-10 Finland
Umbilical hernia without obstruction or gangrene
2.4
6.0
49
210
KH1AD
NOMESCO Finland
CT of urinary organs
2.7
6.0
37
138
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.4
6.0
262
1929
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
2.1
6.0
65
321
A01
ICPC
Pain general/multiple sites
2.0
6.0
73
376
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3022948) Iron [Moles/volume] in Serum or Plasma
639
1377
7.65
312.02
8.8
1.8
umol/l
11.5
13.1
7.94
616
1253
(3004789) Transferrin [Mass/volume] in Serum or Plasma
635
1259
8.34
307.65
8.8
1.8
g/l
2.0
2.3
19.64
613
1148
(3003458) Phosphate [Moles/volume] in Serum or Plasma
840
1034
18.57
307.65
21.0
3.2
mmol/l
1.2
1.0
41.51
808
932
(3020779) Urea [Moles/volume] in Serum or Plasma
783
669
25.01
307.65
21.1
3.4
mmol/l
15.4
9.8
36.94
755
629
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
678
552
22.69
307.65
10.7
2.1
ng/l
174.7
68.0
43.83
625
456
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
610
1171
8.41
307.65
9.1
1.8
%
22.6
23.2
0.61
567
1002
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
262
179
17.74
302.27
5.6
2.2
mg/l
2.4
1.4
27.54
245
157
(3021447) Carbon dioxide [Partial pressure] in Venous blood
476
803
8.43
290.53
11.3
2.5
kpa
5.8
5.8
0.44
465
774
(3002032) Base excess in Venous blood by calculation
473
802
8.36
287.12
11.6
2.5
mmol/l
0.7
2.0
9.53
398
628
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
329
380
10.98
272.37
12.3
2.3
mmol/l
23.0
24.2
6.34
303
334
(3020682) Albumin/Creatinine [Ratio] in Urine
801
2483
6.14
257.22
7.8
3.3
mg/mmol
52.8
4.3
32.06
673
1467
(3000991) Gas panel - Venous blood
433
746
7.93
256.85
13.3
6.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
763
2275
6.12
255.87
6.1
2.4
umol/l
5119.8
7397.2
0.53
701
1916
(3012516) Albumin [Mass/volume] in Urine
762
2360
5.84
241.93
6.6
2.8
mg/l
236.2
304.6
0.37
650
1418
(3009508) Creatinine [Moles/volume] in Urine
767
2437
5.70
234.91
6.6
2.6
mmol/l
5.9
7.8
34.81
708
1983
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
321
447
9.00
227.78
2.3
1.6
g/l
1.6
1.5
0.77
305
368
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
165
101
18.36
199.45
9.4
1.6
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
367
685
6.89
198.12
7.9
2.3
kpa
5.8
4.3
13.76
354
660
(3024561) Albumin [Mass/volume] in Serum or Plasma
964
4258
4.98
182.58
14.2
3.9
g/l
34.1
34.8
3.30
920
3867
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
317
569
6.89
176.64
7.8
2.7
mmol/l
0.7
2.0
6.41
233
417
(3009343) pH of Capillary blood
323
594
6.75
175.68
7.9
2.8
ph
7.4
7.4
4.08
49
57
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
324
607
6.63
172.83
8.0
2.8
kpa
5.1
5.1
0.66
317
542
(3012095) Magnesium [Moles/volume] in Serum or Plasma
509
1436
4.98
171.42
4.7
2.8
mmol/l
0.8
0.8
0.65
479
1305
(3020630) Protein [Mass/volume] in Serum or Plasma
382
870
5.65
165.09
3.0
2.7
g/l
65.4
66.2
1.08
364
775
(3017143) Hepatitis C virus Ab [Presence] in Serum
317
611
6.40
163.80
3.8
1.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
851
3627
4.38
163.58
8.0
2.9
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
233
325
8.39
162.91
2.1
3.8
mg/l
76.7
69.1
0.16
174
275
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
232
323
8.40
162.45
2.1
3.8
mg/l
51.3
77.0
0.32
172
276
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
228
314
8.47
161.08
2.1
3.8
ratio
1.4
1.3
0.15
19
23
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
323
664
6.01
155.54
3.8
1.3
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1003
4983
4.49
151.47
29.0
5.5
mmol/l
1.2
1.2
1.17
889
4168
(3004588) Protein electrophoresis panel - Serum or Plasma
325
725
5.52
142.29
2.0
2.6
—
—
—
0
0
(3018418) pH of Serum or Plasma
708
2871
3.94
140.78
17.9
3.3
ph
7.4
7.4
6.24
139
513
(40760888) Immunoglobulin light chains.free panel - Serum
191
253
8.57
138.81
2.0
3.9
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
419
1184
4.61
137.48
2.9
4.1
u/l
244.8
246.4
0.06
405
1103
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
929
4603
3.97
135.06
22.9
4.9
mmol/l
1.2
1.2
0.71
891
4073
(3020876) Protein [Mass/time] in 24 hour Urine
106
59
19.34
133.31
2.5
2.1
g/24h
2.4
—
—
9
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
130
107
13.28
132.69
2.6
1.2
u/ml
110.9
151.1
0.51
33
21
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
139
128
11.94
132.13
2.5
1.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
779
3504
3.73
129.72
8.4
2.3
ug/l
230.8
180.3
4.78
746
3102
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
141
137
11.32
129.26
10.0
4.2
iu/ml
4817.8
155.9
0.58
35
19
(3027945) Reticulocytes/100 erythrocytes in Blood
414
1217
4.40
128.09
3.3
2.2
%
1.9
1.7
3.91
378
1062
(3000850) Epithelial cells [#/volume] in Urine
567
2091
3.86
127.33
5.5
2.4
e6/l
3.3
4.4
1.69
528
1839
(3010375) cycloSPORINE [Mass/volume] in Blood
72
14
54.14
126.07
21.4
41.2
ug/l
81.6
140.4
2.46
56
14
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
126
108
12.71
125.32
4.6
2.5
u/ml
283.6
1381.8
—
7
16
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
799
3718
3.64
124.83
3.9
2.0
nmol/l
80.2
79.0
0.52
748
3184
(46235355) HIV 1 and 2 tests - Meaningful Use set
329
823
4.91
124.83
3.7
1.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
699
3017
3.61
122.36
7.2
2.9
e6/l
34.5
113.6
2.34
639
2341
(3026782) Osmolality of Urine
532
1927
3.82
121.85
5.9
2.6
mosm/kgh2o
476.5
575.2
31.67
487
1629
(3022313) Gas panel - Capillary blood
234
448
6.06
119.98
8.6
2.8
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
191
303
7.13
117.91
3.2
2.7
u/ml
0.3
0.3
0.89
103
170
(3037121) Protein [Mass/volume] in Urine
187
290
7.28
117.89
5.9
2.3
g/l
0.6
0.2
5.28
120
101
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
120
105
12.40
117.70
1.6
1.1
u/ml
293.3
298.0
0.04
83
61
(3018095) Leukocytes [#/volume] in Urine
748
3438
3.50
117.14
8.3
3.3
e6/l
62.6
119.7
1.51
651
2499
(3018677) aPTT in Platelet poor plasma by Coagulation assay
423
1342
4.07
116.78
2.9
1.9
s
29.7
30.0
0.35
414
1295
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
120
113
11.51
112.12
1.5
1.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
643
2772
3.42
110.16
6.9
2.9
e6/l
0.4
0.5
0.79
565
2103
(1616796) Gas panel - Central venous blood
138
168
9.00
106.81
7.8
3.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
325
912
4.33
105.20
3.8
2.3
e9/l
66.8
63.7
0.87
251
730
(3023368) Bacteria identified in Blood by Culture
639
2811
3.32
104.74
6.9
3.8
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
111
9
133.71
104.67
1.8
1.0
—
—
—
0
0
(3024471) HLA-A [Type]
57
10
59.35
101.51
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
57
10
59.35
101.51
1.0
1.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
83
50
17.57
100.21
2.1
2.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
83
50
17.57
100.21
1.1
1.2
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
154
231
7.36
99.69
5.1
2.8
mmol/l
22.7
25.1
6.45
148
192
(36304419) Bacteria [Presence] in Urine
610
2672
3.26
99.67
6.5
2.8
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
578
2474
3.26
97.86
3.1
2.0
mg/l
3.2
3.0
1.18
519
2033
(3048929) Epstein Barr virus Ab [Presence] in Serum
126
153
8.94
97.58
1.5
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
131
168
8.49
97.07
7.4
1.9
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
73
38
20.20
94.27
1.2
1.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
644
3005
3.10
92.88
4.4
2.7
ng/l
7393.7
1458.5
20.23
583
2582
(3032080) INR in Blood by Coagulation assay
788
4130
3.05
91.97
19.7
8.7
inr
1.4
1.3
0.34
219
1039
(3042936) Bacteria identified in Isolate by Culture
368
1238
3.67
90.92
2.7
1.8
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
95
92
11.00
86.82
1.3
2.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
120
161
8.05
85.45
4.2
2.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
433
1700
3.23
82.66
4.7
2.5
e6/l
0.9
1.0
0.49
305
973
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
155
283
6.03
82.57
1.9
2.6
g/l
0.0
0.1
0.38
146
259
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
181
386
5.23
81.36
1.8
2.7
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
181
386
5.23
81.36
1.8
2.7
g/l
3.8
3.7
0.29
140
278
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
181
386
5.23
81.36
1.8
2.7
g/l
7.6
7.2
1.33
141
290
(3007853) Bacteria identified in Skin by Aerobe culture
309
992
3.71
81.14
2.5
1.5
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
628
3076
2.87
80.12
7.1
5.3
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
180
389
5.16
79.63
9.9
2.8
mmol/l
23.7
24.8
5.01
174
353
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
172
359
5.32
79.17
1.7
2.7
g/l
3.2
3.1
0.83
141
283
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
51
16
33.03
79.05
2.7
2.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
410
1600
3.20
78.58
5.1
2.7
e6/l
1.5
1.6
0.12
286
881
(3014148) Varicella zoster virus Ab [Titer] in Serum
68
47
15.15
76.27
1.1
1.1
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
336
1185
3.41
75.85
10.0
6.1
mmol/l
103.2
104.8
5.36
325
1164
(3001604) Monocytes [#/volume] in Blood
792
4470
2.76
75.39
7.6
5.2
e9/l
0.7
0.6
6.76
701
3770
(3022096) Basophils/100 leukocytes in Blood
744
4085
2.73
74.55
7.9
5.5
%
0.6
0.7
2.50
710
3731
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
161
334
5.31
74.50
1.8
2.8
g/l
0.4
1.7
3.54
147
280
(3014111) Lactate [Moles/volume] in Serum or Plasma
269
833
3.75
74.07
9.3
5.6
mmol/l
1.1
1.4
4.33
259
796
(3006315) Basophils [#/volume] in Blood
794
4514
2.73
74.05
7.6
5.2
e9/l
0.0
0.0
1.35
702
3802
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
143
268
5.82
73.95
1.7
2.6
g/l
0.0
0.0
0.00
135
245
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
141
261
5.89
73.87
1.7
2.7
g/l
0.0
0.0
0.00
135
243
(3013115) Eosinophils [#/volume] in Blood
810
4670
2.72
73.13
7.7
5.4
e9/l
0.2
0.2
5.51
736
3992
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
122
198
6.65
72.95
1.5
1.3
g/l
0.3
0.2
3.61
116
190
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
124
205
6.53
72.82
1.5
1.3
g/l
1.2
1.1
0.46
118
196
(3019198) Lymphocytes [#/volume] in Blood
799
4602
2.69
71.85
7.8
5.3
e9/l
1.6
1.9
2.79
724
3948
(3015736) pH of Urine
654
3426
2.69
71.08
6.2
3.4
—
6.2
—
0
6
(3006504) Eosinophils/100 leukocytes in Blood
750
4209
2.67
70.77
8.2
5.4
%
3.1
2.9
1.20
717
3835
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
149
302
5.40
70.69
1.7
2.5
g/l
36.9
37.6
0.61
138
253
(3019069) Monocytes/100 leukocytes in Blood
750
4223
2.65
70.07
8.6
5.7
%
8.9
9.0
0.77
717
3872
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
292
998
3.43
68.77
5.5
3.2
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
747
4227
2.63
68.64
8.4
5.4
%
62.6
57.7
21.97
708
3868
(3002030) Lymphocytes/100 leukocytes in Blood
755
4302
2.62
68.26
8.5
5.6
%
22.0
26.8
23.84
718
3917
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
161
362
4.89
67.67
1.8
2.8
g/l
10.1
10.5
0.52
150
304
(3035350) Ketones [Presence] in Urine by Test strip
768
4428
2.61
67.51
7.4
3.5
estimate
0.0
0.0
0.00
174
782
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
67
56
12.51
67.23
1.1
1.0
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
65
52
13.05
66.99
1.4
1.4
mu/l
131.2
35.5
1.63
53
43
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
62
46
14.05
66.78
1.5
1.4
pmol/l
252.1
244.8
0.06
45
34
(3037467) Urinalysis macro (dipstick) panel - Urine
999
6590
2.76
65.76
9.8
4.0
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
224
673
3.77
63.97
1.9
1.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
98
145
7.19
63.79
2.0
1.2
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
110
186
6.33
63.05
3.9
2.3
%
16.0
15.8
0.13
85
88
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
65
59
11.50
61.84
1.1
1.1
u/ml
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
390
1670
2.84
61.45
2.2
1.7
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
95
142
7.10
61.24
8.5
1.4
%
76.6
58.3
9.67
95
142
(3019309) Folate [Moles/volume] in Red Blood Cells
473
2243
2.67
60.98
2.2
1.7
nmol/l
1264.5
1172.2
0.86
400
1607
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
98
154
6.76
60.28
3.2
2.0
ug/min
359.5
103.8
1.83
63
85
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
136
293
5.03
59.97
1.7
1.6
titre
142.9
307.0
—
7
20
(3013650) Neutrophils [#/volume] in Blood by Automated count
846
5300
2.49
59.47
9.3
8.7
e9/l
4.9
4.1
15.84
754
4557
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
84
114
7.77
58.98
7.2
5.8
mg/l
12.7
11.5
1.28
76
103
(3013826) Glucose [Moles/volume] in Serum or Plasma
882
5652
2.49
58.66
10.0
4.0
mmol/l
7.2
6.6
12.29
858
5278
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
670
3818
2.44
57.59
6.6
3.3
ng/l
84.0
63.6
0.79
584
2876
(3009261) Glucose [Presence] in Urine by Test strip
750
4499
2.42
57.35
7.6
3.5
estimate
0.0
0.0
0.00
175
768
(3021879) Hepatitis B virus core Ab [Presence] in Serum
162
417
4.26
57.17
2.1
1.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
742
4435
2.42
57.14
10.0
4.7
estimate
0.0
0.0
0.00
182
778
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
125
261
5.16
57.11
1.5
1.5
—
—
—
0
0
(3011648) Oxygen content in Venous blood
60
55
11.35
56.67
4.7
1.2
%
10.6
10.8
0.13
60
55
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
805
5021
2.40
55.80
6.2
5.9
umol/l
10.7
12.5
2.80
769
4751
(3027801) Oxygen [Partial pressure] in Arterial blood
284
1075
3.05
55.50
7.8
6.5
kpa
11.2
12.3
2.50
271
1014
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
284
1075
3.05
55.50
7.8
6.5
kpa
5.0
5.1
0.38
271
1012
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
538
2817
2.47
55.29
2.3
1.9
u/l
167.8
229.4
1.04
512
2623
(3015377) Calcium [Moles/volume] in Serum or Plasma
622
3484
2.40
54.88
6.3
3.3
mmol/l
2.3
2.3
1.95
560
2907
(3026008) Bacteria identified in Urine by Culture
553
2949
2.44
54.39
4.0
3.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
229
775
3.33
53.98
5.2
2.7
ml/min/173m2
32.5
65.5
36.10
142
286
(3004775) Volume in Urine collected for unspecified duration
53
45
12.20
52.56
2.5
1.8
ml
785.4
631.2
1.06
38
28
(3016750) Collection duration of Urine
47
33
14.70
52.08
2.6
1.5
min
483.2
527.6
1.40
35
23
(3031040) Bacteria [#/volume] in Urine by Automated count
951
6538
2.39
50.52
7.7
4.3
e6/l
3238.5
1600.6
0.31
30
87
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
69
89
8.10
50.52
1.6
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
57
8
74.01
50.42
1.0
1.0
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
274
1069
2.94
50.37
8.0
6.5
mmol/l
0.4
1.0
1.30
208
813
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
281
1116
2.89
49.97
2.0
1.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
556
3065
2.34
49.73
4.3
2.4
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
57
9
65.91
49.60
1.0
1.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
185
583
3.50
48.60
1.8
1.4
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
251
951
2.99
48.52
8.2
6.8
%
94.4
95.6
2.42
243
910
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
278
1114
2.86
48.51
2.0
1.6
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1044
7557
2.46
48.07
14.1
6.8
u/l
83.6
78.8
3.08
1013
6970
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
536
2950
2.32
47.69
3.4
2.2
u/l
72.4
59.7
1.68
512
2684
(3037522) Nuclear Ab [Titer] in Serum
244
921
2.99
47.42
1.4
1.3
titre
404.9
627.9
1.18
57
198
(3022217) INR in Platelet poor plasma by Coagulation assay
330
1461
2.64
47.33
37.5
26.9
inr
1.5
1.5
0.13
21
213
(3006184) Hemoglobin [Mass/volume] in Capillary blood
104
219
5.05
46.92
3.4
2.1
g/l
123.1
127.5
0.73
94
139
(3037756) Immunofixation for Serum or Plasma
104
229
4.82
44.49
1.4
1.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
642
3896
2.19
44.11
19.6
8.6
e9/l
0.0
0.0
0.51
518
3135
(3021960) Folate [Moles/volume] in Serum or Plasma
471
2523
2.30
44.00
2.0
1.5
nmol/l
19.7
20.3
0.38
439
2082
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
53
59
9.29
43.56
1.4
1.2
nmol/l
0.1
0.5
—
9
5
(3012501) Base excess in Blood by calculation
92
187
5.19
43.19
10.5
4.0
mmol/l
2.2
2.4
0.29
61
117
(3010421) pH of Blood
101
226
4.74
42.35
10.7
3.6
ph
7.4
7.4
8.33
90
182
(3033658) Prothrombin time (PT) actual/Normal
446
2370
2.29
42.16
6.9
3.4
%
90.7
85.2
3.29
432
2311
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
58
77
7.81
41.39
1.2
1.3
u/l
61.0
75.0
0.48
42
54
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
113
282
4.27
41.27
1.4
1.2
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
154
479
3.49
41.07
8.7
8.2
mmol/l
24.0
24.3
0.59
140
446
(40761535) Cells panel - Urine sediment
232
930
2.79
39.94
7.5
3.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
48
53
9.34
39.67
1.4
1.2
nmol/l
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
686
4398
2.09
39.53
6.4
3.9
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
101
239
4.47
39.49
2.5
1.6
—
—
—
0
0
(40758558) Short blood count panel - Blood
424
2285
2.22
38.11
7.2
6.6
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
27
11
25.00
38.03
2.4
1.4
ng/l
205.7
97.6
2.18
27
11
(3011397) Hemoglobin [Presence] in Urine by Test strip
411
2194
2.23
37.77
6.2
3.6
—
—
—
0
0
(3025315) Body weight
36
0
+∞
37.67
5.2
0.0
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
216
871
2.75
36.59
8.7
7.3
g/l
111.8
119.9
6.03
206
836
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
47
57
8.49
36.11
1.4
1.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
198
768
2.84
36.09
17.2
3.0
mmol/l
1.2
1.2
1.31
182
658
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
666
4336
2.01
35.61
2.7
1.9
pmol/l
98.6
94.0
1.64
359
2202
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
56
85
6.82
35.46
6.7
2.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
434
2421
2.14
35.31
4.2
2.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
102
272
3.96
33.99
2.4
1.4
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
133
425
3.35
33.85
2.2
1.7
ug/l
6.0
2.8
0.59
126
371
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
217
923
2.60
32.87
2.6
2.2
ug/l
6.9
7.8
0.22
180
777
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
169
632
2.90
32.85
2.1
1.6
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
66
128
5.36
32.60
1.2
1.3
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
38
43
9.05
30.78
1.3
1.8
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
333
1769
2.15
30.07
1.8
1.6
mg/l
1.7
1.5
0.50
282
1382
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
437
2570
2.01
30.00
3.6
2.8
u/l
36.2
36.2
0.00
419
2426
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
338
1852
2.08
27.90
5.4
3.4
ng/l
248.5
586.1
1.78
310
1542
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
131
469
2.98
27.42
9.5
8.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
530
3419
1.88
27.07
8.3
3.8
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
378
2187
1.99
26.69
1.9
1.7
pmol/l
29141563.9
27153886.1
0.02
326
1753
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
82
223
3.84
26.54
1.5
1.9
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
102
321
3.35
26.52
1.4
1.8
u/l
37.6
39.7
0.47
90
272
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
210
967
2.38
26.51
3.2
2.4
umol/l
7.5
8.8
0.31
184
860
(3013707) Erythrocyte sedimentation rate by Westergren method
920
7078
1.86
26.19
5.9
3.8
mm/h
25.0
12.6
45.45
851
6374
(3036481) Cortisol [Moles/volume] in Serum or Plasma
158
644
2.64
25.85
2.0
2.2
nmol/l
338.4
372.8
1.39
147
579
(3052851) Hemolysis interference index of Serum or Plasma
89
262
3.56
25.66
5.0
3.3
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
70
175
4.16
25.43
1.6
1.4
g/l
24.2
33.6
6.75
57
160
(3028026) IgM [Mass/volume] in Serum or Plasma
125
460
2.88
24.86
2.0
2.0
g/l
1.1
1.8
1.61
114
418
(3029937) Albumin [Presence] in Urine by Test strip
413
2516
1.91
24.76
8.6
3.8
estimate
0.0
0.0
0.50
136
754
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1137
9452
2.04
24.65
42.4
13.5
mg/l
25.2
28.2
2.55
1049
7410
(3005719) IgG [Mass/volume] in Serum or Plasma
147
596
2.64
24.27
2.1
3.0
g/l
10.6
11.1
0.48
139
540
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
62
147
4.37
24.13
1.3
1.4
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
175
777
2.43
23.86
3.5
2.3
u/l
37.5
40.3
0.18
156
671
(3041096) Erythrocytes [Presence] in Urine by Automated
373
2222
1.92
23.79
7.8
3.2
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
63
153
4.26
23.78
1.6
1.4
e6/l
494.3
1919.4
4.53
43
116
(3036525) Urea [Moles/time] in 24 hour Urine
22
0
+∞
22.98
3.7
0.0
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
72
198
3.78
22.94
1.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
72
198
3.78
22.94
1.4
1.3
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
62
155
4.14
22.53
1.5
2.1
umol/l
24.4
34.2
2.58
55
120
(3036603) Volume of Urine
28
32
8.91
22.46
1.8
1.7
ml
1634.7
1991.9
—
6
8
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
22
18
12.40
22.11
1.1
1.0
miu/ml
1438.8
1422.3
0.02
22
18
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1064
8795
1.85
21.47
11.3
5.1
mmol/mol
42.5
39.1
22.04
1017
7824
(3028308) Erythrocytes [#/volume] in Pleural fluid
58
145
4.13
21.08
1.6
1.4
e6/l
32569.0
85918.6
0.60
35
92
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
20
0
+∞
20.88
4.7
0.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
148
646
2.44
20.87
5.4
4.3
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
57
142
4.14
20.81
1.2
1.2
u/l
16.4
69.2
2.28
49
119
(40768806) Pleura Pathology biopsy report
55
134
4.23
20.68
1.4
1.6
—
—
—
0
0
(3017704) Immunofixation for Urine
35
59
6.06
20.02
1.2
1.9
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
51
123
4.26
19.44
1.6
1.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
161
758
2.27
19.06
5.1
4.0
%
0.6
1.0
1.69
61
245
(3021440) Promyelocytes/100 leukocytes in Blood
153
715
2.28
18.42
5.3
4.0
%
0.0
0.1
4.04
59
222
(3044927) Protein electrophoresis panel - Urine
47
111
4.35
18.41
1.4
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
54
144
3.86
17.99
1.5
1.4
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
24
30
8.12
17.92
1.5
1.5
mg/l
56.6
92.5
0.54
19
21
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
39
81
4.92
17.85
2.1
1.6
—
1840.0
—
0
6
(3025159) Blasts/100 leukocytes in Blood
141
647
2.31
17.70
5.6
4.2
%
0.0
0.3
1.89
56
176
(3002179) Metamyelocytes/100 leukocytes in Blood
147
692
2.25
17.37
4.8
3.9
%
0.5
0.7
0.56
52
170
(3008152) Bicarbonate [Moles/volume] in Arterial blood
132
598
2.33
17.06
8.7
6.9
mmol/l
22.9
24.5
3.20
122
551
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
171
868
2.10
16.70
3.2
2.5
ng/l
676.8
238.0
3.66
159
780
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1039
8771
1.70
16.66
6.3
3.7
mmol/l
1.5
1.2
28.50
982
7679
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
715
5519
1.60
16.40
3.9
2.8
u/l
60.2
49.0
2.43
666
4965
(3002385) Erythrocyte distribution width [Ratio]
910
7442
1.63
16.37
50.6
16.5
%
14.5
13.8
38.24
896
7240
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
30
53
5.76
16.37
1.1
1.4
titre
238.6
197.3
—
7
11
(3040151) Glucose [Moles/volume] in Capillary blood
42
101
4.26
16.09
10.1
4.6
mmol/l
7.1
7.0
0.03
34
84
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
94
374
2.62
16.05
2.8
2.9
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
52
147
3.63
15.95
1.5
1.3
mmol/l
57.0
63.6
0.66
46
119
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
32
63
5.17
15.56
1.4
1.5
u/ml
38.8
18.3
—
6
8
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
66
221
3.08
15.50
1.5
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
66
224
3.04
15.15
1.4
1.6
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
29
54
5.46
14.98
5.7
2.2
mg/l
422.2
15.8
2.31
24
40
(40760892) CBC W Ordered Manual Differential panel - Blood
286
1782
1.76
14.94
5.8
4.4
—
—
—
0
0
(3020891) Body temperature
100
428
2.44
14.67
7.1
4.2
—
—
—
0
0
(3033926) Protein [Mass/volume] in Peritoneal dialysis fluid
14
0
+∞
14.61
8.0
0.0
g/l
1.6
—
—
14
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
55
171
3.31
14.60
1.4
1.6
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
32
67
4.86
14.52
1.5
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
55
172
3.29
14.47
1.5
1.6
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
21
29
7.34
14.42
1.2
3.9
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1057
9102
1.64
14.20
6.8
4.2
mmol/l
1.3
1.5
39.34
1004
8052
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
31
66
4.78
13.80
1.5
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
65
231
2.90
13.78
1.4
1.6
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
162
868
1.98
13.57
2.0
2.1
g/l
0.2
0.2
2.69
147
814
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
13
0
+∞
13.56
5.5
0.0
umol/l
445.0
—
—
13
0
(3025941) Bacteria identified in Stool by Culture
97
426
2.37
13.44
1.5
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
44
126
3.57
13.27
1.3
1.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
58
198
3.01
13.21
1.2
1.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
819
6724
1.52
12.91
4.1
3.6
pmol/l
15.1
15.0
1.08
750
5876
(3036489) Thrombin time
68
257
2.73
12.87
1.7
2.1
s
22.5
22.3
0.09
63
229
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
45
134
3.44
12.81
1.4
1.5
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
60
214
2.88
12.65
2.0
1.7
iu/ml
0.1
0.1
0.07
11
44
(3022689) Creatine [Moles/volume] in Urine
13
11
11.92
12.64
3.8
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1057
9195
1.59
12.64
6.9
4.2
mmol/l
4.1
4.6
57.97
1006
8202
(3019550) Sodium [Moles/volume] in Serum or Plasma
1148
10191
1.67
12.63
55.5
15.3
mmol/l
139.4
139.7
3.18
1127
9842
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
15
16
9.46
12.56
2.7
4.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
48
151
3.26
12.54
1.3
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
312
2078
1.64
12.50
7.5
4.0
kg/l
1.0
1.0
0.39
50
283
(3044889) 12 lead EKG panel
820
6776
1.50
12.21
5.4
3.7
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
41
119
3.52
12.14
1.3
1.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1038
9036
1.56
11.93
38.8
12.8
ml/min/173m2
39.3
75.8
234.56
923
7400
(3023103) Potassium [Moles/volume] in Serum or Plasma
1147
10223
1.65
11.92
57.8
15.3
mmol/l
4.2
4.0
48.55
1124
9850
(40761511) CBC panel - Blood by Automated count
1113
9859
1.61
11.73
42.9
12.8
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
202
1217
1.77
11.66
1.2
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
60
224
2.75
11.64
1.3
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
44
138
3.26
11.56
1.3
1.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
107
523
2.13
11.48
2.6
2.4
—
—
—
0
0
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
11
0
+∞
11.47
5.0
0.0
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
11
0
+∞
11.47
8.1
0.0
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
43
135
3.25
11.29
2.3
1.3
nmol/l
1.5
0.7
1.71
33
109
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
24
49
4.97
11.23
1.6
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
24
49
4.97
11.23
1.6
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1072
9472
1.55
10.82
7.3
4.7
mmol/l
2.2
2.7
73.41
1023
8375
(3000093) Morphology [Interpretation] in Blood Narrative
30
76
4.01
10.78
1.2
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
36
105
3.49
10.61
1.2
1.3
miu/ml
290.2
227.5
—
7
46
(3007164) IgA [Mass/volume] in Serum or Plasma
221
1401
1.68
10.58
1.6
1.5
g/l
2.9
2.6
0.86
159
793
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
23
48
4.85
10.50
1.0
1.2
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
23
48
4.85
10.50
1.0
1.2
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
60
237
2.60
10.45
4.7
2.9
nmol/l
0.9
0.9
0.21
42
177
(3013512) EKG study
419
3093
1.50
10.44
6.5
3.6
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
10
0
+∞
10.43
3.1
0.0
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
25
57
4.45
10.28
1.3
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
133
733
1.90
10.21
9.6
3.6
—
—
—
0
0
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
11
10
11.08
10.17
1.1
1.0
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
11
10
11.08
10.17
1.6
1.1
mmol/l
1.2
1.2
—
11
10
(3015171) Extractable nuclear Ab [Units/volume] in Serum
62
253
2.52
10.12
1.2
1.2
u/ml
0.4
1.0
—
5
22
(3000570) Elastase.pancreatic [Mass/mass] in Stool
62
253
2.52
10.12
1.4
1.4
ug/g
270.5
280.5
0.16
45
158
(3019225) pH of Specimen
195
1211
1.71
10.06
20.5
3.6
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
973
8477
1.47
10.04
5.1
4.3
mu/l
2.3
2.0
1.82
905
7416
(3002256) Pathology report gross observation
203
1283
1.68
9.80
1.7
1.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
35
106
3.36
9.75
1.5
1.5
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
14
19
7.43
9.71
2.9
3.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
176
1075
1.73
9.63
1.6
1.4
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
11
11
10.07
9.55
1.4
1.1
mmol/l
1.2
1.2
1.28
11
11
(3045414) Leukocytes [Presence] in Urine
83
397
2.16
9.44
3.9
1.8
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1129
10186
1.54
9.42
19.3
9.5
u/l
23.0
25.1
2.14
1102
9641
(3038071) Oxygen [Partial pressure] in Mixed venous blood
12
14
8.64
9.35
21.6
7.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
25
62
4.09
9.26
1.2
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
26
68
3.88
8.98
1.3
1.3
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
12
5
24.17
8.91
1.1
1.2
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
13
18
7.28
8.85
22.4
7.7
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
20
43
4.70
8.83
2.0
2.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
91
465
2.02
8.71
8.1
3.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
43
158
2.78
8.66
2.3
3.5
%
58.5
59.3
0.16
43
158
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
29
85
3.46
8.52
1.6
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
93
483
1.99
8.51
2.5
1.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
560
4504
1.40
8.44
2.9
2.3
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
21
49
4.34
8.41
1.8
1.7
u/l
14.8
5.9
0.90
12
26
(3005570) Glucose [Moles/volume] in Urine
32
101
3.22
8.39
2.7
2.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
18
37
4.91
8.37
1.4
3.8
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
87
444
2.02
8.37
2.2
1.7
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
8
0
+∞
8.34
1.4
0.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
157
971
1.69
8.19
1.5
1.3
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
22
55
4.05
8.08
1.9
1.2
—
—
—
0
0
(4035726)
145
884
1.71
7.97
1.5
1.3
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
14
24
5.88
7.86
1.1
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
325
2404
1.46
7.68
1.5
1.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
31
102
3.08
7.61
5.8
2.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
96
526
1.89
7.53
2.7
2.7
—
—
—
0
0
(3022621) pH of Urine by Test strip
108
618
1.81
7.39
4.4
3.0
—
—
—
0
0
(3000012) Reticulocyte production index
20
50
4.04
7.36
1.6
1.6
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
27
84
3.26
7.27
1.5
1.1
u/ml
6.3
4.7
0.22
17
38
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
31
105
3.00
7.26
1.3
1.3
u/l
7.2
12.8
3.93
24
98
(3021788) Differential panel - Synovial fluid
38
145
2.67
7.17
1.3
1.5
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
78
411
1.95
6.89
2.4
3.3
pmol/l
3.9
4.4
4.53
62
350
(3045424) Erythrocytes [Presence] in Urine
37
143
2.63
6.82
3.4
1.3
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
13
24
5.46
6.77
2.6
3.2
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
1149
10616
1.44
6.55
61.0
20.0
e9/l
7.6
6.7
17.29
1121
10156
(3009542) Hematocrit [Volume Fraction] of Blood
931
8312
1.35
6.53
42.8
14.7
%
35.6
39.3
20.46
603
5303
(3007461) Platelets [#/volume] in Blood
1148
10607
1.44
6.53
60.8
20.0
e9/l
231.5
236.4
1.71
1123
10195
(3035941) MCH [Entitic mass]
1148
10611
1.44
6.48
60.6
19.9
pg
30.5
30.6
0.34
1129
10327
(3026361) Erythrocytes [#/volume] in Blood
1148
10612
1.44
6.46
60.8
20.0
e12/l
4.1
4.4
67.40
1118
10159
(3024731) MCV [Entitic volume]
1148
10612
1.44
6.46
60.6
19.9
fl
93.0
91.9
11.46
1128
10328
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
280
2075
1.44
6.45
3.6
2.9
mmol/l
2.5
2.4
2.51
225
1812
(3000963) Hemoglobin [Mass/volume] in Blood
1148
10614
1.44
6.44
61.1
20.1
g/l
122.9
134.9
85.51
1129
10334
(3011436) Histone Ab [Units/volume] in Serum
11
18
6.15
6.43
1.0
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
32
119
2.73
6.37
4.3
3.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
180
1224
1.54
6.35
1.2
1.2
u/ml
12.9
11.2
0.12
56
443
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
12
22
5.49
6.29
1.2
1.2
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
20
57
3.54
6.17
1.2
1.3
%
43.5
25.3
1.26
14
32
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
20
57
3.54
6.17
1.3
1.3
%
60.3
67.3
0.31
11
44
(3044941) Cell count panel - Synovial fluid
34
134
2.58
6.06
1.5
1.3
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
40
173
2.35
5.87
1.1
1.2
—
1808.3
—
0
6
(1761482) Bacteria [#/volume] in Urine by Culture
50
238
2.14
5.85
7.2
4.4
—
—
—
0
0
(3004451) EKG impression Narrative
15
36
4.20
5.83
1.9
1.3
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
46
213
2.20
5.77
1.6
1.6
e6/l
7880.6
11375.8
0.71
34
157
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
23
77
3.02
5.54
1.3
1.3
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
28
105
2.70
5.52
1.3
1.5
g/l
0.8
0.7
0.11
23
81
(3051651) Icteric interference index of Serum or Plasma
17
47
3.65
5.49
3.6
3.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
17
47
3.65
5.49
3.2
1.7
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
59
309
1.95
5.37
5.1
4.2
mmol/l
4.1
4.0
0.76
52
297
(3014891) Appearance of Pleural fluid
10
18
5.59
5.32
1.9
1.4
—
—
—
0
0
(44790047)
26
96
2.74
5.28
1.3
1.4
—
—
—
0
0
(44806118)
26
96
2.74
5.28
1.3
1.4
—
—
—
0
0
(44790049)
26
96
2.74
5.28
1.3
1.4
—
—
—
0
0
(44790048)
26
96
2.74
5.28
1.3
1.4
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
11
22
5.03
5.26
4.4
3.1
%
59.5
61.5
0.10
11
22
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
33
138
2.42
5.24
1.2
1.2
—
—
—
0
0
(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count
5
0
+∞
5.21
6.4
0.0
%
0.6
—
—
5
0
(40768443) Skin Pathology biopsy report
73
417
1.79
5.09
1.3
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
305
2386
1.35
4.99
2.0
1.6
mmol/l
1.5
1.2
4.06
268
1981
(3051387) C reactive protein [Mass/volume] in Capillary blood
43
206
2.12
4.99
5.1
3.0
mg/l
32.4
28.9
0.24
32
106
(3004616) Nuclear Ab [Presence] in Serum
28
111
2.55
4.98
1.2
1.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1019
9368
1.31
4.96
7.5
4.5
mmol/l
6.3
5.9
18.42
944
8195
(3042111) Morphology [Interpretation] in Bone marrow Narrative
40
188
2.16
4.88
1.3
1.7
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
24
89
2.73
4.85
3.2
3.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
11
24
4.61
4.78
4.1
2.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
15
42
3.60
4.77
1.8
2.1
u/l
153.0
1398.7
—
5
12
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
17
53
3.23
4.62
1.1
1.4
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
17
53
3.23
4.62
1.1
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
17
53
3.23
4.62
1.3
1.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
31
134
2.34
4.61
1.6
1.4
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
16
48
3.36
4.61
1.1
1.1
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
16
48
3.36
4.61
1.3
1.4
%
1.2
2.2
—
9
38
(40759836) Histone Ab [Presence] in Serum by Immunoblot
16
48
3.36
4.61
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
16
48
3.36
4.61
1.1
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
5
227
0.22
4.58
1.4
1.6
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
7
5
14.06
4.58
1.9
1.0
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
23
87
2.67
4.50
1.3
1.6
%
59.9
59.8
0.00
14
49
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
17
54
3.17
4.49
1.3
1.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
30
130
2.34
4.45
1.6
1.4
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
13
35
3.74
4.37
1.0
1.0
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
13
35
3.74
4.37
1.0
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
13
35
3.74
4.37
1.0
1.0
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
16
50
3.23
4.34
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
16
50
3.23
4.34
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
16
50
3.23
4.34
1.1
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
22
83
2.68
4.33
1.7
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
30
132
2.30
4.31
1.6
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
30
132
2.30
4.31
1.6
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
25
102
2.48
4.23
1.0
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
41
207
2.01
4.19
4.5
2.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
20
73
2.76
4.19
1.4
1.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
43
221
1.98
4.19
1.6
1.4
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
22
85
2.61
4.15
1.0
1.1
iu/ml
1.0
25.3
—
5
12
(3047181) Lactate [Moles/volume] in Blood
50
274
1.86
4.04
7.7
5.2
mmol/l
1.2
1.4
0.87
45
231
(3024263) Appearance of Synovial fluid
16
53
3.04
3.97
1.6
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
173
1286
1.39
3.86
1.2
1.2
iu/ml
37.2
40.2
0.14
52
374
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
49
272
1.83
3.82
1.3
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
29
133
2.21
3.81
1.6
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
29
133
2.21
3.81
1.6
1.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
17
60
2.86
3.80
1.1
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
25
108
2.34
3.77
3.0
3.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
22
90
2.47
3.72
1.5
1.1
u/ml
2.7
5.8
—
10
35
(3014765) Yersinia sp identified in Stool by Organism specific culture
49
275
1.81
3.70
1.3
1.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
9
16
5.65
3.66
2.4
1.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
23
97
2.39
3.66
1.0
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
49
278
1.79
3.58
1.3
1.2
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
7
9
7.81
3.56
1.6
2.4
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
7
9
7.81
3.56
1.6
2.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
23
99
2.35
3.51
1.1
1.8
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
26
526
0.48
3.45
2.2
1.7
—
—
—
0
0
(4306422)
20
82
2.46
3.39
1.2
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
10
27
3.72
3.35
1.1
1.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
32
162
2.00
3.31
2.5
3.0
—
—
—
0
0
(3034426) Prothrombin time (PT)
9
19
4.76
3.24
1.2
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
578
5124
1.22
3.21
4.3
5.5
ug/l
2.7
5.4
1.88
529
4539
(40768804) Tissue Pathology biopsy report
447
3862
1.23
3.19
2.8
2.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
8
15
5.36
3.19
1.9
1.4
—
—
—
0
0
(4268621)
16
62
2.60
3.05
2.9
2.0
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
9
21
4.31
2.99
1.2
1.4
—
3.8
—
0
11
(4024509)
24
114
2.12
2.95
2.0
1.7
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
20
88
2.29
2.94
1.1
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
24
115
2.11
2.89
1.2
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
119
877
1.39
2.84
2.0
2.2
ug/g
159.6
138.4
0.40
100
668
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
21
96
2.21
2.84
1.1
1.8
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
5
6
8.36
2.75
3.2
1.2
—
—
—
0
0
(4146454)
20
91
2.21
2.74
2.2
2.8
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
55
349
1.60
2.74
1.4
1.2
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
7
14
5.02
2.73
1.3
1.0
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
9
24
3.77
2.67
2.1
1.6
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
9
24
3.77
2.67
1.4
1.2
—
—
—
0
0
(3000492) Spirometry study
102
741
1.41
2.66
1.5
1.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
19
86
2.23
2.64
1.2
1.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
16
347
0.45
2.64
1.8
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
23
439
0.52
2.63
1.2
1.3
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
7
15
4.68
2.60
1.4
1.8
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
15
4.68
2.60
1.0
1.8
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
15
4.68
2.60
1.0
1.8
—
—
—
0
0
(3003338) MCHC [Mass/volume]
827
7685
1.18
2.50
52.6
18.0
g/l
327.9
332.0
29.21
816
7584
(44806420)
9
26
3.48
2.48
2.2
2.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
11
268
0.41
2.45
1.2
1.5
mg/l
3.2
3.1
0.02
11
193
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
20
96
2.10
2.43
1.2
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
20
96
2.10
2.43
1.2
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
20
96
2.10
2.43
1.2
1.6
—
—
—
0
0
(21494434) Karyotype in Bone marrow
21
103
2.05
2.42
1.0
1.2
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
6
12
5.02
2.40
1.0
1.2
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
21
104
2.03
2.36
2.8
2.6
nmol/l
8.2
4.6
0.66
21
104
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
13
52
2.51
2.36
2.8
1.9
u/field
8.3
2.2
—
7
29
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
13
52
2.51
2.36
1.2
1.3
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
11
41
2.70
2.28
1.0
2.0
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
10
36
2.79
2.20
1.1
1.2
mmol/l
14.6
13.3
—
5
9
(3029075) Extractable nuclear Ab panel - Serum
8
24
3.35
2.18
1.1
1.0
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
175
1420
1.27
2.18
6.8
4.2
%
33.3
32.9
0.22
160
840
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
18
87
2.08
2.17
1.2
1.0
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
7
19
3.70
2.15
1.4
1.8
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
14
61
2.31
2.15
1.2
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
58
398
1.48
2.10
2.6
3.2
u/ml
49.9
3606.9
0.78
50
332
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
144
1148
1.28
2.07
2.5
4.2
ug/l
7.7
23.9
1.41
125
956
(4010399)
94
707
1.35
2.04
1.3
1.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
21
111
1.91
2.01
1.5
1.2
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
5
11
4.56
1.94
8.8
8.9
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
6
16
3.76
1.93
1.3
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
11
46
2.40
1.85
4.1
2.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
190
1588
1.23
1.84
1.2
1.2
u/ml
1.0
1.8
1.12
39
380
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
10
40
2.51
1.83
1.0
2.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
10
40
2.51
1.83
1.0
2.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
78
582
1.36
1.81
4.1
3.2
e9/l
4.7
4.1
0.89
64
395
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
98
759
1.31
1.78
1.7
1.7
%
1.9
1.6
1.94
81
639
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
11
47
2.35
1.78
2.5
1.6
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
6
19
3.17
1.66
1.0
1.0
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
7
25
2.81
1.65
1.0
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
40
269
1.50
1.65
1.6
1.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
20
112
1.80
1.65
1.6
1.3
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
5
14
3.58
1.61
2.2
2.8
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
6
20
3.01
1.58
1.2
1.0
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
10
207
0.48
1.55
1.8
1.7
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
24
145
1.67
1.54
1.1
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
13
64
2.04
1.54
1.8
11.3
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
5
15
3.34
1.52
1.0
1.2
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
7
27
2.60
1.51
2.6
2.5
—
—
—
0
0
(40768441) Liver Pathology biopsy report
11
51
2.17
1.50
1.5
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
8
166
0.48
1.47
1.3
1.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
9
38
2.38
1.45
1.2
1.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
11
52
2.12
1.44
1.2
1.2
—
—
—
0
0
(4062490)
13
66
1.98
1.43
1.7
1.3
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
16
90
1.79
1.33
3.3
2.0
u/field
1.0
1.4
—
6
26
(3021387) Prolactin [Units/volume] in Serum or Plasma
21
129
1.64
1.30
1.3
1.6
mu/l
413.9
280.2
1.40
21
120
(3035320) C reactive protein [Mass/volume] in Body fluid
12
62
1.94
1.28
1.4
2.0
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
10
48
2.09
1.28
2.2
2.3
e9/l
0.3
0.2
—
10
42
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
13
70
1.87
1.24
3.2
3.6
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
11
56
1.97
1.22
1.0
1.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
16
93
1.73
1.21
1.1
1.3
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
22
140
1.58
1.20
2.0
2.6
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
8
38
2.11
1.18
1.0
1.0
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
7
30
2.34
1.12
1.3
1.1
iu/ml
610.6
293.0
—
7
30
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
22
329
0.66
1.11
1.4
1.5
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
53
408
1.31
1.09
1.1
1.2
iu/ml
64.8
118.5
0.59
17
141
(3003327) Ova and parasites identified in Stool by Light microscopy
33
237
1.40
1.05
1.6
1.6
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
12
67
1.80
1.04
1.0
1.1
u/ml
1.5
2.6
—
5
27
(40768800) Prostate Pathology biopsy report
26
369
0.70
1.02
1.2
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
7
35
2.00
1.00
1.1
2.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
96
804
1.21
0.99
1.4
1.5
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
29
0.00
0.97
0.0
1.4
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
6
27
2.23
0.93
1.2
1.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
6
27
2.23
0.93
1.0
1.4
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
12
70
1.72
0.92
2.8
2.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
10
55
1.82
0.92
1.0
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
10
55
1.82
0.92
1.0
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
10
55
1.82
0.92
1.0
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
10
55
1.82
0.92
1.0
1.8
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
8
44
1.82
0.86
1.0
1.0
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
41
318
1.30
0.84
1.0
1.1
—
285.0
—
0
8
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
8
45
1.78
0.84
1.0
1.0
mg/l
35.3
35.2
—
8
35
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
5
26
1.93
0.70
1.6
3.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
29
375
0.77
0.69
1.1
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
5
27
1.85
0.68
1.2
1.4
—
—
—
0
0
(4094501)
18
250
0.72
0.68
1.3
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
22
295
0.74
0.67
1.4
1.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
13
86
1.52
0.66
1.2
1.8
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
10
63
1.59
0.62
1.0
1.1
—
—
—
0
0
(4027681)
5
30
1.67
0.61
1.2
1.2
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
25
191
1.31
0.61
1.1
1.3
mg/l
552.4
568.4
0.07
25
174
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
10
65
1.54
0.55
1.1
1.2
—
—
—
0
0
(4015189)
6
38
1.58
0.54
2.0
1.7
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
6
39
1.54
0.53
3.7
1.2
—
—
—
0
0
(3048879) Bone marrow aspiration report
6
39
1.54
0.53
1.0
1.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
32
391
0.81
0.51
1.3
1.3
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
7
45
1.56
0.49
6.1
6.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
7
45
1.56
0.49
1.9
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
7
109
0.64
0.48
1.0
1.6
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
21
166
1.27
0.43
1.3
1.3
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
5
31
1.62
0.43
1.2
1.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
5
34
1.47
0.40
1.2
1.1
mmol/l
5.9
6.7
—
5
34
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
21
169
1.25
0.38
1.1
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
19
151
1.26
0.38
1.1
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
24
197
1.22
0.37
1.6
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
14
108
1.30
0.35
1.4
1.8
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
6
43
1.40
0.35
1.2
1.2
u/l
158.3
518.5
—
6
38
(1002224) Polysomnography panel
20
244
0.82
0.35
1.1
1.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
6
44
1.37
0.34
1.3
1.3
g/l
0.9
1.0
—
6
44
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
26
218
1.20
0.34
1.2
1.2
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
6
45
1.33
0.33
5.7
4.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
13
102
1.28
0.30
1.3
1.4
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
20
166
1.21
0.30
1.3
1.4
e6/l
882.5
878.9
0.00
20
129
(1761868) Lipid panel - Serum or Plasma
281
2702
1.05
0.29
4.7
2.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
8
110
0.73
0.29
1.0
1.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
8
111
0.72
0.28
1.0
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
8
111
0.72
0.28
1.0
1.6
—
—
—
0
0
(4281824)
9
72
1.25
0.25
1.1
1.1
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
22
256
0.86
0.25
1.7
1.6
nmol/l
46.6
46.7
0.00
22
243
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
19
160
1.19
0.25
1.5
1.9
iu/l
2.1
4.1
—
5
54
(36660697) Celiac disease serology panel - Serum
63
579
1.09
0.25
1.2
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
9
75
1.20
0.25
1.0
1.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
82
0.73
0.24
1.2
1.0
—
—
—
0
0
(44813793)
5
39
1.28
0.23
1.0
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
40
1.25
0.22
1.0
1.1
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
5
40
1.25
0.22
6.8
5.8
—
86.9
—
0
10
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
41
1.22
0.22
1.4
2.6
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
84
894
0.94
0.21
2.4
2.0
nmol/l
10.1
13.2
2.92
73
785
(3025130) Human papilloma virus identified in Specimen
5
42
1.19
0.21
1.8
1.6
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
8
103
0.78
0.21
1.0
1.6
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
292
3004
0.96
0.20
2.8
3.2
ug/l
0.9
0.8
0.80
221
2118
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
3.3
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
0
14
0.00
0.20
0.0
1.6
—
7.5
—
0
8
(4211845)
6
50
1.20
0.19
5.7
4.0
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
6
53
1.13
0.18
20.8
2.4
%
13.7
13.1
—
6
53
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
19
166
1.15
0.18
1.2
1.4
e6/l
2.2
12.3
1.14
19
122
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
7
61
1.15
0.17
1.0
1.1
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
19
168
1.13
0.15
1.2
1.3
mmol/l
3.9
3.7
0.31
19
152
(3011288) Drugs identified in Urine by Screen method
6
78
0.77
0.15
1.0
2.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
9
78
1.15
0.15
1.3
1.2
—
—
—
0
0
(4034850)
35
323
1.09
0.14
16.4
10.8
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
409
4160
0.98
0.14
4.0
4.6
%
27.5
21.4
9.48
221
2202
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
12
105
1.14
0.11
1.4
1.4
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
5
47
1.06
0.09
1.0
1.2
nmol/l
156.6
143.8
—
5
47
(3013139) Helicobacter pylori Ag [Presence] in Stool
59
566
1.04
0.09
1.2
1.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
6
57
1.05
0.08
1.0
1.9
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
5
64
0.78
0.08
1.0
1.0
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
9
88
1.02
0.07
3.0
2.0
ug/l
2.1
2.0
—
9
78
(1001926) Buprenorphine [Presence] in Urine by Screen method
8
92
0.87
0.06
1.0
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
62
639
0.97
0.06
1.4
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
95
940
1.01
0.02
1.2
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
17
176
0.97
0.00
1.0
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
145
1451
1.00
0.00
21.0
6.7
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
13
135
0.96
0.00
1.1
1.4
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
8
82
0.98
0.00
1.0
1.1
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
9
89
1.01
0.00
1.1
1.2
mmol/l
9.7
7.5
—
9
58
(3026470) Cobalt [Mass/volume] in Blood
9
90
1.00
0.00
2.8
2.0
ug/l
5.7
3.1
—
9
83
(3003740) Influenza virus B Ag [Presence] in Specimen
8
82
0.98
0.00
1.0
1.1
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
56
560
1.00
0.00
2.2
2.5
—
15.0
—
0
18
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
7
79
0.89
0.00
1.3
1.2
—
—
—
0
0
(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum
0
5
0.00
-0.00
0.0
1.0
—
0.0
—
0
5
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint I9_HYPTENSRD and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| I9_HYPTENSRD | 2.586 [2.17, 3.08] | < 0.001 |
| Birth year | 0.994 [0.99, 1.0] | 0.155 |
During the follow-up period (1.1.1998 — 31.12.2019), 1318 out of 2344 females with I9_HYPTENSRD died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| I9_HYPTENSRD | 2.628 [2.25, 3.08] | < 0.001 |
| Birth year | 0.986 [0.98, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 2041 out of 3952 males with I9_HYPTENSRD died.
Mortality risk
Mortality risk for people of age
years, who have I9_HYPTENSRD.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.294% | 0.514% |
| 5 | 1.466% | 3.231% |
| 10 | 3.662% | 7.2% |
| 15 | 6.979% | 13.563% |
| 20 | 12.004% | 21.28% |
Relationships between endpoints
↥Index endpoint: I9_HYPTENSRD – Hypertensive Renal Disease
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data